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Abstract 
Unravelling novel molecular targets for photobiomodulation in human hair 
follicle towards the development of more effective light-based therapies 
for hair growth 
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Light and optical techniques have made a profound impact on modern medicine 
both in diagnostics and in therapy. Therapeutic action of light is based on 
photomechanical, photothermal, photochemical and photobiological 
interactions, depending on the wavelength, power density, exposure time and 
optical properties of tissue and cells. Last decade experienced a growing rise of 
commercial devices for management of hair growth, where all of them are 
based on low levels of light resulting into photobiological, non-thermal 
interaction of photons with cells, a process that recently has received an official 
term ‘photobiomodulation’. However, the design and analysis of the reported 
clinical studies are highly debated in a wider scientific community. The picture is 
further complicated by a virtual lack of proof about the exact molecular targets 
that mediate the physiological response of skin and hair follicles (HF) to low 
levels of light. 
The goal of this project was to investigate the expression of light-sensitive 
receptors in the human HF and to study the impact of UV-free blue light on hair 
growth ex vivo. The expression of Cryptochromes 1 and 2 (CRY1, 2), Opsin 2 
and 3 (OPN2 and OPN3), but not other Opsins 1, 4 and 5 was detected in the 
distinct compartments of skin and anagen HF. Evaluation of the physiological 
role of detected light-sensitive receptors on hair growth was performed by the 
modulation of photoreceptors activity in HF ex vivo model. HFs treated with 
KL001, a stabilizer of CRY1 protein that lengthens the circadian period, delayed 
HF anagen-catagen transition; while silencing of CRY1 induced premature 
catagen development accompanied by reduced cell proliferation. Silencing of 
CRY1 in the HF outer root sheath (ORS) cells in vitro caused downregulation of 
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genes involved in the control of proliferation; including the cyclin dependent 
kinase 6 (CDK6). OPN3 also had a positive effect on metabolic activity and 
proliferation of the ORS cells in vitro. OPN3 silencing resulted in the altered 
expression of genes involved in the control of proliferation and apoptosis. 
Investigated CRY1, OPN2 and 3 greatly absorb in the blue to green-region of 
the visible spectrum. This led us to investigate the effect of blue light on HF 
growth. Daily treatment with blue light (453 nm, 3.2 J/cm2, 16 nm full width half 
maximum) prolonged anagen phase in HF ex vivo that was associated with 
sustained proliferation. In addition, blue light (3.2 J/cm2) significantly stimulated 
proliferation of ORS cells in vitro. This effect was abrogated by silencing of 
OPN3. 
To summarize, CRY 1, OPN 2 and OPN 3 are expressed in the distinct 
compartments of the HF, including HF stem cells. Blue light (453 nm) at low 
radiant exposure exerts a positive effect on hair growth ex vivo, potentially via 
interaction with OPN3. The further research should be conducted to decipher 
interactions between blue light and the investigated receptors in the HFs. In 
addition, the beneficial effect of blue light at low radiant exposure on hair growth 
raises a possibility of increasing therapeutic efficacy when combined with 
topical chemistry used for management of hair growth.  
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1 Introduction 
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1.1 Biology of the hair follicle 
The hair follicle (HF) is one of the most complex “mini-organ” (Schneider et al. 
2009) in the body and plays a variety of physiological roles: it is involved in the 
temperature regulation, immune defense, touch sensation, sexual selection, 
and wound repair (Ito et al. 2005; Stenn and Paus 2001). In addition, HF has 
also important functions in the social life of human; indeed hair loss can have a 
negative impact on people’s life. Different kinds of alopecia have been 
described; the most prevalent is androgenetic alopecia (AGA) that affect 50% of 
the male population by the age of 50 (Price 2003).The existing pharmacological 
treatments of AGA show some positive effects, but there is no definitive solution 
for this problem yet. This project aims to understand the biological effects 
triggered by low level laser therapy or photobiomodulation in the HF in order to 
develop more effective light-based solutions for the hair re-growth.  
 
1.1.1 Hair follicle structure and cellular composition 
Within the skin HFs are organized in pilosebaceous units composed of the HF, 
the sebaceous gland (SG) and the arrector pili muscle (APM). The SG is an 
acinar gland composed of lipid-filled sebocytes; it secretes sebum that, for 
example, helps making hair and skin waterproof (Schneider et al. 2009). The 
APM is a tiny smooth muscle that when contracted causes the ‘raising’ of the 
hair. The mature anagen HF can morphologically be divided into three regions: 
the infundibulum, isthmus and the hair bulb (Figure 1-1 A). The infundibulum 
represents the uppermost portion of the HF; it forms the junction between the 
HF and the epidermis and includes the opening of the hair canal to the skin 
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surface. The isthmus is the middle portion of the HF, which is situated between 
the SG duct opening and the attachment site for the APM; it harbors the bulge 
region (Figure 1-1 B) containing epithelial and melanocyte stem cells (Ohyama 
et al. 2006; Snippert et al. 2010). The lower portion of the HF, hair bulb, 
contains the hair matrix, consisting of the actively proliferating epithelial cells 
and pigment producing melanocytes, which envelopes an area of densely 
populated fibroblast cells called the dermal papilla (DP) (Paus and Foitzik 2004; 
Schneider et al. 2009) (Figure 1-1 C). The rapidly proliferating matrix 
keratinocytes contribute to the HF formation by generating the different cell 
lineages: the inner root sheath (IRS), including the companion layer, Henle’s 
layer, Huxley’s layer and cuticle and the hair shaft (HS), including the cuticle, 
cortex and the medulla (Schneider et al. 2009) (Figure 1-1 D). Functionally, the 
IRS serves as a rigid funnel-shaped protection covering the HS: the flattened 
corneocytes of the cuticle of the IRS overlap and interlock intimately with the 
cells of the cuticle of the HS ensuring that the IRS and the growing hair ascend 
upwards in the follicle together (Joshi 2011; Kreplak et al. 2001; Paus and 
Foitzik 2004). The outermost layer of the IRS, the companion layer, acts as a 
slippage layer allowing the HS to slide past the ORS and grow upwards (Paus 
and Foitzik 2004). The IRS is essential for the proper molding, adherence, and 
keratinization of the growing HS. The Flugzellen cells of Huxley's layer are 
postulated to function as nutritive canals between the not keratinized Huxley's 
layer and the ORS, bypassing the fully cornified and impermeable Henle's layer 
(Joshi 2011). Interestingly, in the condition described as loose anagen hair of 
childhood, premature keratinization of the IRS has been implicated in the loss of 
the anchoring function and subsequent deformation of the HS (Hamm and 
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Traupe 1989; Tosti and Piraccini 2002). The ORS is created from local 
progenitor cells located in bulge region and acts as a local paracrine signal 
source within the HF (Sequeira and Nicolas 2012). The bulge is clearly visible in 
mouse HFs, as a group of cells protruding from the side of the follicle; though in 
humans the bulge is not structurally distinct (Treuting and Dintzis 2011). Cells 
that are hosted in the bulge have the typical properties of epithelial stem cells: 
they are the slowest-cycling and longest-lived cells within the HF (Cotsarelis et 
al. 1990; Lyle et al. 1998). The stem cells are biochemically distinct cells and 
can be identified by molecular markers such as CD34 in mouse and CD200 in 
human HFs (Cotsarelis 2006; Ohyama et al. 2006).  
The HF also contains neural crest-derived pigment producing melanocytes 
(Tobin and Bystryn 1996), Langerhans’ cells that are dendritic antigen-
presenting cells (Gilliam et al. 1998) , and Merkel cells, specialized 
neurosecretory cells (Kim and Holbrook 1995). Interestingly, these cells have 
the ability to repopulate the epidermis after injury. Also, they allow the HF to act 
as a sensory organ and immunologic sentinel for the skin: the HF detects 
mechanical stimuli relaying sensory information to the nervous system (Paus 
and Cotsarelis 1999). Langerhans’ cells located at the opening of the HF detect 
surface pathogens and activate the immune system (Gilliam et al. 1998).  
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Figure 1-1 Histomorphology of the human hair follicle.  
(A) Sagittal section through a human scalp HF (anagen VI) showing the 
permanent (infundibulum, isthmus) and anagen associated (suprabulbar and 
bulbar area) components. (B) High magnification image of the isthmus. The 
dashed square indicates the approximate location of the bulge. (C) High 
magnification image of the bulb. (D) Schematic drawing illustrating the 
concentric layers of the outer root sheath (ORS), inner root sheath (IRS) and 
shaft (HS) in the bulb. The IRS is composed of four layers: Companion layer 
(CL), Henle’s layer, Huxley’s layer, and the cuticle. (BM: basal membrane; 
APM: arrector pili muscle; CTS: connective tissue sheath; DP: dermal papilla; 
M: matrix; SG: sebaceous gland). Adapted from (Schneider et al. 2009) 
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1.1.2 Hair cycle 
To produce a new HS the HF undergoes repetitive cycles consisting of active 
growth (anagen), regression (catagen) and relative resting (telogen) phases 
(Figure 1-3). In mice hair cycle occurs rapidly, moving in a caudal to rostral 
wave, with each cycle lasting around 25 days. The first two cycles follow well 
defined timings, allowing the hair cycle to be easily studied (Muller-Rover et al. 
2001). The human hair cycle is much longer and asynchronous: anagen in 
scalp HF can last for up to 8 years. The duration of the anagen phase 
determines hair length (Cotsarelis 2006) and differs depending on body areas 
(Paus and Cotsarelis 1999).  
Anagen involves the complete regeneration of the lower cycling portion of the 
HF, the HS factory (Figure 1-1 C). Historically the anagen phase has been 
divided into 6 different sub-phases by Chase et al (Chase 1965), which do not 
differ substantially in time except for the phase VI, the duration of which 
determine the length of the HS. During each anagen phase, HF produces an 
entire HS from tip to the root. An intense cross talk between DP cells and 
progenitor cells take place in order to trigger the anagen onset (Schneider et al. 
2009). Transplantation studies have shown that DP cells from rodent vibrissae, 
when implanted into the hair less skin exhibit the capacity to form new HFs 
(Jahoda et al. 1984); this observation was later confirmed by another group, 
also showing that not only DP cells but also transplanted peribulbar dermal 
sheath cells were able to induce HF development (McElwee et al. 2003). At the 
onset of anagen, cells of the secondary hair germ, a structure that forms during 
the late catagen phase consisting of a population of progenitor cells (Ito et al. 
2004), grow down into the dermis and form the distinct epithelial lineages. 
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Anagen I is associated with the activation of mitotic activity of the epithelial 
progenitors that migrate together with the DP downwards the dermis. In anagen 
II, a newly forming hair matrix begins to enclose the DP, while in anagen III-IV 
the matrix cells initiate their differentiation into at least 8 HF lineages. The newly 
forming HS begins to appear at anagen V and emerges from the skin at anagen 
VI (Muller-Rover et al., 2001). During anagen VI, hair matrix keratinocytes 
rapidly proliferate and act as suppliers of the cells to the HS. The 
melanogenesis is strictly coupled to anagen progression (Muller-Rover et al. 
2001; Slominski et al. 2004).  
Research published by Cotsarelis group identified putative stem cells in rodent 
HF as quiescent label-retaining cells (LRCs) in in-vivo studies (Cotsarelis et al. 
1990). Bulge cells in adult mice generate all epithelial cells types within the 
intact follicle, as demonstrated by performing lineage tracing analysis of EGFP-
labelled K15-positive bulge cells in mice (Morris et al. 2004). Transplantation of 
human scalp tissue onto immune-deficient mice confirmed that human HFSC 
are slowly-cycling in nature and with high proliferative potential and localized 
within the bulge area that is positive for cytokeratin 15 (K15) (Lyle et al. 1998). 
Ohyama et al work defined the bulge in the human HF (Ohyama et al. 2006). 
The group developed the method of navigated laser capture microdissection (N-
LCM) to isolate bulge ORS cells and delineate biological distinctiveness of 
these cells by analyzing gene expression pattern (Ohyama et al. 2006). The 
analysis compared the profile of bulge cells with sub-bulge ORS cells: it 
revealed a new surface protein that now is considered as candidate bulge stem 
cells markers, CD200. The work highlighted several key differences between 
mouse and human gene expression in HF stem cells: in particular, CD34, which 
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is considered an excellent bulge cell marker in mouse (Trempus et al. 2003), is 
not the preferential marker of bulge stem cells in human HF. Instead, K15 and 
CD200 are preferentially expressed in human HFSC (Figure 1-2) (Cotsarelis 
2006; Ohyama et al. 2006). When the supply of matrix cells declines, the 
differentiation of IRS and HS of the cycling portion regresses and the follicle 
enters the involution (catagen) phase (Paus and Foitzik 2004). 
Figure 1-2 CD200 is a cell-surface marker for the bulge ORS cells  
(A) CD200 is preferentially expressed on the defined bulge ORS and the 
companion layer of human anagen HF. (B) Upper panel illustrates the mRNA 
expression pattern of CD200 and CD34 in human HF. The orange gradient 
indicates the expression intensities of CD200 and CD34 transcripts. Lower 
panels demonstrate the expression pattern of each marker in the transverse 
sections of different levels of the same HF. Red and blue arrowheads indicate 
the levels of bulge and sub-bulge, respectively. Scale bars: 50 μm. (Adapted 
from (Ohyama et al. 2006) 
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Catagen is characterized by apoptotic-driven degradation of the lower cycling 
portion of the HF (Botchkareva et al. 2006; Schneider et al. 2009). The catagen 
phase involves the cessation of cell proliferation and pigmentation, loss of the 
layered differentiation of the lower follicle, extracellular matrix remodeling and 
shrinkage of the inferior follicle by the process of apoptosis (Schneider et al. 
2009). Apoptosis distribution in HF during catagen has a wave pattern starting 
from the melanogenic area, propagating to the hair matrix and in late catagen to 
the central ORS, IRS and HS (Botchkareva et al. 2006). As the cycling portion 
regresses the DP, now a cluster of quiescent cells not affected by apoptotic 
events, comes into contact with the bulge region (Schneider et al. 2009). 
Contact between the DP and bulge cells is very important. Failure of these 
interactions in both, humans and mice, leads to the hair loss: for example, hr 
(hairless) gene mutation results in the disintegration of the DP and the HF 
epithelium during catagen that causes arrest of the HF cycling activity, 
development of the epithelial cysts and, eventually, hair loss (Ahmad et al. 
1998; Panteleyev et al. 1998).  
Morphologically catagen phase can be divided into 8 stages (Straile et al. 
1961). During the first two early stages of catagen the hair matrix and DP are 
reduced in size (Straile et al. 1961). In the next three stages (mid), the DP 
becomes ball shaped and narrows; epithelial strand and club hair are formed 
(catagen V) (Botchkareva et al. 2006). Late stages (catagen V-VIII) are 
morphologically defined by a shortening of the HF.  
Telogen was recognized as a resting stage where the HF is quiescent; 
however, a growing number of studies demonstrated the major changes in gene 
activity within the telogen skin (Geyfman et al. 2012a; Greco et al. 2009). Two 
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stages of telogen have recently been identified: refractory and competent 
stages (Paus and Cotsarelis 1999; Plikus et al. 2008). During the refractory 
period high levels of bone morphogenetic protein (BMP) signaling prevents 
anagen initiation (Plikus 2012; Plikus et al. 2008). In the competent telogen, the 
bulge stem cells become highly sensitive to anagen promoting signals; the BMP 
signaling activity is reduced and HFs are entering new anagen phase (Greco et 
al. 2009; Plikus 2012; Plikus et al. 2008).  
Exogen is the hair shedding phase that was first characterized by the Stenn 
group as a highly regulated process (Milner et al. 2002). By examining the shed 
and plucked telogen hair shafts they observed distinctive morphological 
features in their bases. In shed hairs the base of hair fibers have sculpted 
edges and are bordered by cell membranes with deteriorating nuclei, whereas 
plucked telogen HS showed a smooth edge and rich in intact nucleated cells 
(Milner et al., 2002). This indicates that the exogen triggering event is the 
proteolytic separation of the mooring cells (Milner et al. 2002), suggesting that 
hair shedding is not a passive event (Higgins et al. 2011).  
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Figure 1-3 Key stages of the hair cycle  
The hair cycle consists of three different phases: anagen (growth phase), 
catagen (regression phase) and telogen (quiescent phase). APM: arrector pili 
muscle; DC, dermal condensate (green); DP: dermal papilla (green); HS: hair 
shaft (brown); IRS: inner root sheath (blue); MC: melanocytes; ORS: outer root 
sheath; SC: sebocytes (yellow); SG: sebaceous gland. (Adapted from 
(Schneider et al. 2009)  
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1.1.3 Molecular mediators of hair cycle 
Epithelial-mesenchymal interactions are fundamental drivers of the hair cycle. 
At least six major growth factor families are now recognized to be important in 
this context, including bone morphogenetic proteins (BMP), Sonic Hedgehog 
(SHH), Wingless (WNT), fibroblast growth factor (FGF), transforming growth 
factor TGF-beta, epidermal growth factor (EGF), tumor necrosis factor (TNFα) 
and neurotrophin families (reviewed in (Botchkarev and Kishimoto 2003; Millar 
2002).  
Refractory telogen is molecularly characterized by up-regulation and activation 
of BMP2/4 ligands produced by the HFs (Botchkarev et al. 2001; Greco et al. 
2009) and the surrounding dermal microenvironment (Plikus et al. 2008). WNT 
signaling is very low, partly because of the WNT antagonists present in the 
dermal macro-environment (Plikus et al. 2011). Low levels of FGF7 in the DP 
also maintain the refractory phase (Greco et al. 2009). BMP4 functions by 
binding to the transmembrane serine/threonine kinase receptor BMPR1A, that 
is broadly expressed in the epidermis and HF (Botchkarev 2003), resulting in 
phosphorylation of SMADs 1,5 and 8. Phosphorylated SMADs bind to SMAD4 
and translocate into the nucleus, where they form the complex with transcription 
factors and regulate transcription of target gene like Dkk1, an inhibitor of the 
Wnt-beta-catenin signaling pathway (Mishina 2003). Reduction in the BMP2/4 
signaling is mediated by Noggin, the BMP antagonist that prevents binding of 
BMPs to BMPR1A, leading into the competent telogen, when WNT protein 
signaling is turned on (Botchkarev et al. 2001; Plikus et al. 2008).  
The peak of activity of Wnt/β-catenin in early anagen is necessary for the 
initiation of a new hair cycle and HS differentiation: absence of β-catenin 
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induces hair loss and HFSC fail to differentiate into follicular keratinocytes, 
instead they adopt an epidermal fate (Huelsken et al. 2001). While not required 
for anagen onset, Shh is necessary for subsequent events, including 
proliferation of epithelial cells and down-growth of the HF into the dermis (Wang 
et al. 2000). The ectopic expression of Shh achieved by the administration of an 
E1(-) adenovirus vector, AdShh, into the mouse back skin causes significant 
acceleration of anagen onset (Sato et al. 1999).  
The increase in TGF-β1 and FGF5 activities promotes catagen development in 
HFs (Hansen et al. 1997; Hebert et al. 1994; Oshimori and Fuchs 2012). 
Experimental deletion of TGF-β1 in mice prolongs anagen, whereas 
administration of TGF-β1 induces pre-mature anagen-catagen transition, 
suggesting its essential role in triggering catagen (Foitzik et al. 2003). FGF5-
deficient mice exhibit a prolonged anagen phase resulting in an angora hair 
phenotype (Hebert et al. 1994). In human HF, FGF-5 expression was observed 
in the upper ORS and in small round cells surrounding the HF (Higgins et al. 
2014). The same study demonstrated that mutations in the human FGF5 gene 
are associated with familial trichomegaly (or extreme eyelash growth), and that 
FGF5 inhibits hair growth in an organ culture model by initiating catagen 
(Higgins et al. 2014). The human counterpart to the mouse angora phenotype 
was disclosed, suggesting that in human FGF-5 could also induce catagen by 
binding to FGF-R1 expressed in the DP (Ota et al. 2002) 
Other molecules worthy to be mentioned in controlling catagen entry are 
Vitamin D receptor (Bikle et al. 2006; Palmer et al. 2008), the transcriptional 
repressor Hairless (Panteleyev et al. 1998) and the retinoic acid receptor 
(Foitzik et al. 2005). A representation of mentioned key factors involved in the 
14 
 
hair cycle is given in Figure 1-4. Taken together, multiple elements need to be 
involved in the regulation of the hair cycle: spatio-temporal changes of signal 
transducers are needed for progression or maintenance of the HF during the 
distinct hair cycle phases, however none of these factors act as the pace-maker 
of the cycling by itself. 
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Figure 1-4 Molecular players in hair cycle control  
The figure shows key factors that drive the HF through the hair cycle stages. 
BMP, bone morphogenetic protein; WNT, wingless; STAT3, signal transducer 
and activator of transcription 3; FGF7, fibroblast growth factor 7; HGF, 
hepatocyte growth factor; Shh, sonic hedgehog; IGF1, insulin like growth factor; 
CTSL, cathepsin L; cutl, transcriptional repressor; GDNF, glial cell line-derived 
neurotrophic factor; BDNF, brain-derived nerve growth factor; VEGF, vascular 
endothelial growth factor; ATRA, all-trans retinoid acid; RXR, retinoid x receptor; 
RAR, retinoid acid receptor; NGF, nerve growth factor; Lef1, lymphoid 
enhancer-binding protein; TGFβ, transforming growth factor β; p75NTR, low 
affinity neurotrophin receptor; PRL, prolactin; PRLR, prolactin receptor; IFN, 
interferon ; ER, estrogen receptor; IL1, interleukin 1; VR1, vanilloid receptor 1; 
TNF, tumor necrosis factor; TSP1, thrombospondin 1. (Krause and Foitzik 
2006) 
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1.2 Essentials of Hair Health 
Male and female pattern hair loss is a common disorder affecting 30 and 50% of 
women and men, respectively, by the age of 50 (Norwood 2001; Severi et al. 
2003). The slow, relentless, involuntary loss of hair creates emotional stress for 
millions of men and women. Alopecia is a generic term for hair loss that results 
from a diminution of visible hair. Alopecia can be classified as cicatricial or 
scarring alopecia and non-cicatricial. Cicatricial alopecia refers to a group of 
rare disorders that destroy the HF replacing it with scar tissue causing the 
permanent hair loss (Templeton and Solomon 1994). The most common forms 
of non-cicatricial alopecia are androgenetic alopecia (AGA) and alopecia areata 
(AA) (Cotsarelis and Millar 2001). 
 
1.2.1 Androgenetic Alopecia 
AGA is the most common form of hair loss in men affecting almost 50% of the 
male population by the age of 50 (Norwood 1975; Severi et al. 2003). Estimates 
of its prevalence in women have varied widely, though recent studies claim that 
six percent of women aged under 50 years are affected, increasing to a 
proportion of 30–40% in women aged 70 years and over (Norwood 2001). AGA 
refers to hair loss in individuals with a genetic predisposition caused by effects 
of androgens such as testosterone and its derivative dihydrotestosterone (DHT) 
(Price 1999; Trueb 2002). It is assumed that the genetically predisposed HFs 
are the target for androgen-stimulated HF miniaturization, leading to gradual 
replacement of large, pigmented hairs (terminal hairs) by barely visible hairs 
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(vellus hairs) in affected areas (Paus and Cotsarelis 1999). This results in a 
progressive decline in visible scalp hair density.  
Testosterone is a hormone that diffuses across the cell membrane. It's 
converted by the cytoplasmic enzyme 5-α-reductase to DHT, which is five-fold 
more potent than testosterone, based on its affinity for the androgen receptor 
(Trueb 2002). There are two types of 5-α-reductase: the type 1 isozyme 
represents the 'cutaneous type'; it is mainly located in sebocytes, but also can 
be expressed in epidermal and HF keratinocytes, DP cells and sweat glands as 
well as in the fibroblasts from genital and non-genital skin. The type 2 isozyme 
is expressed mainly in the prostate, in the fibroblasts of normal adult genital 
skin, in the IRS (Chen et al. 1998) and in the ORS of the HFs (Sawaya and 
Price 1997). People affected by AGA have higher levels of 5-α-reductase, more 
androgen receptors, and lower levels of cytochrome P-450 aromatase (Sawaya 
and Price 1997), suggesting that the observed clinical patterns of AGA may 
reflect quantitative differences in the levels of these enzymes. 
All steroid hormones act by diffusing through the plasma membrane into the 
target cell and binding to specific intracellular receptors. The androgen receptor 
(AR) is believed to be responsible for determining the sensitivity of cells to 
androgens (Banka et al. 2013) (Quigley 1998): expression of the AR has been 
found to be increased in balding scalp (Sawaya and Price 1997) and 
polymorphism of the AR gene has been found to be associated with AGA (Ellis 
et al. 2001). While major progress has been done in the understanding of 
androgen metabolism, the genetic predisposition to AGA remains poorly 
understood. It has been hypothesized that AGA has polygenic inheritance that 
is dependent on a combination of mutations, e.g. in or around the AR gene 
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affecting the expression of the AR, and other genes controlling androgen levels 
(Trueb 2002).  
While a genetic predisposition to an increased HF sensitivity to androgens is a 
prerequisite for AGA development, clinical practice has shown that simply 
blocking androgens does not results in the conversion of miniaturized HFs into 
terminal ones in advanced AGA. Interestingly, histologic examination of bald 
scalp biopsies shows that miniaturization of terminal HF is frequently associated 
with perifollicular lymphocytic infiltration, and eventually fibrosis (Jaworsky et al. 
1992; Mahe et al. 2000; Whiting 1993). Therefore, it is conceivable that the role 
of this “microscopic follicular inflammation” causing fibrosis participates in 
preventing restoration of a terminal HF (Trueb 2002).  
The role of stem cell differentiation in AGA should also be taken into account. In 
a recent work Garza et al (2011) compared HF stem cells obtained from bald 
versus non-bald scalp areas of AGA donors and quantified the expression of 
stem- and progenitor cell markers. They found that K15+ cells are present in the 
HFs obtained from both balding and non-balding scalp samples. However, they 
found the decrease in a well-demarcated population of cells CD200high/ITGA6high 
in bald versus haired scalp. These cells were intermediate in size compared to 
K15hi cells, and localized in the bulge region and the secondary germ of telogen 
HF from haired scalp. Because of these features CD200high/ITGA6high cells were 
classified as progenitor cells. In addition, 10-fold decrease in CD34+ cells 
population was observed in bald versus haired scalp (Garza et al. 2011).  
These findings suggest that AGA develops not as a result of loss of HFSC, but 
a diminished conversion of stem cells into the progenitor cells. The preservation 
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of stem cell population in AGA can be the key feature to improve the 
reversibility of this condition, while the loss of progenitor cell population can 
provide insights into possible mechanisms leading to HF miniaturization.  
 
1.2.2 Alopecia areata  
Alopecia Areata (AA) is one of the most prevalent autoimmune diseases, 
affecting approximately 5.3 million people in the United States alone, including 
males and females across all ethnic groups (Alkhalifah et al. 2010; Harries et al. 
2010; Safavi 1992). The disease usually initiates as a hair loss patching normal-
appearing skin, which can occur anywhere on the body, although the scalp is 
the most common site. AA develops due to the collapse of the “immune 
privilege” of the HF that is characterized by aberrant expression of major 
histocompatibility complexes (MHC class Ia) antigens and a reduced synthesis 
of important immunosuppressant, such as alpha-MSH and TGF-beta1(Safavi et 
al. 1995; Tan et al. 2002; Tosti and Duque-Estrada 2009; Tosti et al. 2008). AA 
is often associated with others autoimmune disorders such as vitiligo, celiac 
disease and diabetes (Goh et al. 2006; Kuchabal and Kuchabal 2010; Kurtev 
and Iliev 2005; Wang et al. 1994). The course of the disease is notoriously 
unpredictable: the initial patches can coalesce and progress to cover the entire 
scalp (alopecia totalis, AT) or eventually the entire body (alopecia universalis, 
AU) (Olsen et al. 2004; Sehgal and Jain 2003). The HFSC are generally not 
destroyed, therefore the HF retains its capacity to regenerate and continue 
cycling such that AA can spontaneously remits (Gilhar et al. 2012). AA 
preferentially affects pigmented anagen HF; when hair regrowth occurs within 
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the AA patches, it frequently grows back white or colorless (Cline 1988; Gilhar 
et al. 2012).  
The early stage of AA is characterized by the attack of the anagen HF by T 
cells; they form peri- and intra-follicular inflammatory infiltrates leading to an 
abrupt conversion from anagen to catagen and ultimate HS shedding (Gilhar et 
al. 2012; Wasserman et al. 2007; Whiting 2003). The infiltrates are mainly 
composed of CD4+ and CD8+ T lymphocytes; in addition, the numbers of NK 
cells and mast cells are greatly increased in the perifollicular infiltrates 
(Bodemer et al. 2000; Cetin et al. 2009; Dressel et al. 1997).  
The hypothesized pathogenesis of AA is a collapse of immune privilege of the 
HF, when pro-inflammatory signals upregulate MHC-Ia expression in the 
proximal HF epithelium (Paus et al. 2005). In this condition, follicular 
autoantigens (Gilhar et al. 2001) are not sequestered any longer and can be 
presented in the normally MHC Ia-negative epithelial hair bulb (Paus et al. 
2005). In presence of appropriate co-stimulatory signals, autoreactive CD8+ T 
cells, CD4+ T cells and cytotoxic NK cells attack the hair bulb (Paus et al. 
1993). This activates a vicious cycle of secondary follicle-damaging 
autoimmune phenomena, whose quality and magnitude largely determine the 
resulting degree of HF damage and, thus, the actual clinical manifestation, hair 
loss (Paus et al. 1993).  
Genetic predisposition plays an important role in AA development. Recent 
genome wide association studies identified susceptibility loci for AA on 
chromosomes 6p (HLA), 6q (UL 16 binding protein, (ULBP), 10p (IL2RA), and 
18p (PTPN22) (Martinez-Mir et al. 2007; Petukhova et al. 2010). Furthermore, a 
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number of genes were identified that may be associated with AA and other 
autoimmune diseases, such as ULBP, which encodes a class of ligands 
activating NKG2D receptors (Petukhova et al. 2010). 
 
1.2.3 Overview of available treatments 
For AGA the available pharmacological treatments consist of two drugs: 
Minoxidil (DeVillez et al. 1994; Jacobs et al. 1993) and Finasteride, which are 
approved by The Food and Drug Administration (FDA). Both drugs can increase 
coverage of the scalp by enlarging existing hairs and retard further thinning in 
both the vertex and the frontal regions. However, the response differs among 
patients and neither drug restores all the hair (Price 1999). 
Minoxidil is a potassium channels opener and vasodilator (Buhl et al. 1993). Its 
mechanism of action with respect to the stimulation of hair growth is not known, 
but it appears to be independent of vasodilatation (Buhl 1991), and is probably 
linked to the stimulation of VEGF (Lachgar et al. 1998). It is administrated as 
topic solution that significantly increases hair count (Rietschel and Duncan 
1987), although efficacy is variable and temporary. The adverse effects of 
topical Minoxidil are mainly dermatologic (Price 1999). Some beneficial effects 
of Minoxidil were also observed in AA patients.  
Finasteride, a competitive inhibitor of type II 5-α-reductase that blocks the 
conversion of testosterone to its active metabolite, DHT (Rittmaster 1994). 
Finasteride treatment is safe and well tolerated: in male adverse effects of 
sexual functions were reversible (Rittmaster 1994).  
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Patients with AA are treated with either immune-modulating therapies, such as 
glucocorticoids (Sawaya and Hordinsky 1995) or topical immunotherapy 
(Shapiro and Price 1998). Both treatments exert several adverse effects, such 
as persistent dermatitis, painful cervical lymphadenopathy, generalized eczema, 
blistering, contact leukoderma, and urticarial reaction (Singh and Lavanya 
2010). Notably, a recent work by the Christiano’s laboratory reported a near-
complete hair regrowth in three AA patients treated with oral ruxolitinib (Xing et 
al. 2014). This chemotherapeutic drug acts by inhibiting Janus kinase (JAK) 
family protein tyrosine kinases (JAK1 and 2), downstream effectors of the IFN-γ 
and γ-cytokine receptors that are expressed by infiltrative T cells. This 
successful experiment has opened the possibility for systematic clinical trials of 
JAK inhibitors for AA treatment (Jabbari et al. 2015; Kennedy Crispin et al. 
2016). 
Other available approaches for AGA treatment include hair transplant surgery 
(Rose 2015), often in combination with treatments that prevent hair loss, such 
as the use of growth factors present in the platelet-rich plasma fraction (Singh 
and Goldberg 2016) or prostaglandin E2 (PGE2) (Garza et al. 2012; Johnstone 
and Albert 2002). However, because of its high costs, such treatments are not 
affordable for many people.  
Up to now the list of light-based devices for the management of hair regrowth 
with FDA 510k premarket notification clearance counts thirty two entries 
(Jimenez et al. 2014; Lanzafame et al. 2013; Lanzafame et al. 2014; Leavitt et 
al. 2009). The efficacy of light-based therapy is reported to be similar to that of 
existing FDA-approved drugs (Minoxidil and Finasteride) (Kim et al. 2013a; 
Leavitt et al. 2009; Munck et al. 2014) and more important free of potential side 
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effects (Mysore 2012). Nevertheless, observed effects are still not fully 
cosmetically acceptable. Moreover, the design of the reported clinical studies 
and the accuracy of the hair count has been contested (Mignon et al. 2016a). 
The picture is further complicated by a virtual lack of proof about the exact 
molecular targets that mediate the physiological response of skin and HF to low 
levels of light. Unrevealing these targets is of primary importance to improve 
current technologies and deliver novel light-based solutions for hair loss. An 
introduction of the already known basic principles of light interactions with skin 
will be given below. 
 
1.3 Basic principles of Photobiomodulation 
Photobiomodulation (PBM) has clinically been reported to have a positive 
impact on hair growth (Jimenez et al. 2014; Lanzafame et al. 2013; Lanzafame 
et al. 2014; Leavitt et al. 2009), skin rejuvenation (Dierickx and Anderson 2005; 
Rinaldi 2008), wound healing (Gupta et al. 1998; Hopkins et al. 2004; Kajagar et 
al. 2012), psoriasis (Pfaff et al. 2015; Weinstabl et al. 2011) and eczema 
(Keemss et al. 2016). The lack of the risk of potential systemic side effects is 
well recognized as a benefit in the treatment of cutaneous disorders (Metelitsa 
and Green 2011; Mysore 2012). PBM defined the therapeutic use of visible to 
near infrared radiation (NIR) light absorbed by endogenous chromophores, 
triggering non-thermal, non-cytotoxic, biological reactions through 
photochemical events (Anders et al. 2015). In November 2015, the term 
‘Photobiomodulation Therapy’ was formally adopted as an ofﬁcial NIH U.S. 
National Library of Medicine (MeSH) term: biostimulation, low-level laser (or 
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light) therapy (LLLT), low-intensity laser therapy, low-power laser therapy, cold 
laser, soft laser, photobiostimulation were the other names previously used for 
this therapy (Anders et al. 2015). Photobiomodulation therapy results in 
beneficial therapeutic outcomes, including, but not limited to, tissue 
regeneration (Hopkins et al. 2004), alleviation of inflammation (Weinstabl et al. 
2011) and pain (Naeser 2006). Endre Mester introduced the phenomenon of 
using light for hair regeneration in 1967 (Mester et al. 1967). To test if laser 
radiation might cause cancer in mice, he irradiated mouse back skin with a low 
power ruby laser (694 nm). As a result, he didn't observed neoplastic formations 
in treated mice, while he noticed a quicker hair regrowth compared to the 
untreated mice (Mester et al. 1967). Since this observation, several clinical 
studies reported encouraging results demonstrating the increase in hair density 
and thickness in response to red and near infrared light-based therapy. 
However, the molecular mechanism underlying light-mediated hair regrowth 
remain largely unknown. To understand the various modalities of laser-tissue 
interaction, it is necessary to understand how photons penetrate biological 
tissues and their molecular triggers. 
 
1.3.1 Optical properties of biological tissues 
When photons strike the surface of the tissue, a portion (4–10%) of photons are 
reflected according to the angle of incidence due to the refractive index change 
(Steiner 2011). Photons penetrating the surface initially are refracted, obeying 
the law of Snellius. In biological tissues, like the skin, the photons may be 
scattered or absorbed, exciting the absorbing molecule by an electronic 
transition (Steiner 2011).  
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Blood, melanin and water are the main absorbing components in biological 
tissues (Jacques 2013). Others photosensitive molecules are porphyrin, flavin, 
retinol, nuclear acids, deoxyribonucleic acid (DNA)/ribonucleic acid (RNA), and 
reduced nicotinamide adenine dinucleotide (Bachmann et al. 2006). While peak 
of absorption for water is in the NIR range of the light spectrum, others 
molecules mainly absorb light in the visible range, between 400 nm and 700 nm 
(Jacques 2013).  
The scattering behavior of biological tissues is also important, because it 
determines the volume distribution of light intensity in the tissue. Scattering is 
the primary step for tissue interaction, followed by absorption and heat 
generation (Steiner 2011). Scattering of a photon is accompanied by a change 
in the propagation direction without loss of energy that influences light 
penetration depth (Steiner 2011).  
In correlation to scattering and absorption, skin penetration of light is maximized 
between 600 and 1200 nm, which is called an “optical window” (Huang et al. 
2009). 
 
1.3.2 Light-tissue interactions  
Applying different light parameters such as irradiance (power density) and 
exposure time, it is possible to induce distinct reactions in tissues like the skin 
(Figure 1-5): 1) photoablation, where the damage is confined to the specific 
tissue structures and preconditions for tissue ablation are high absorption and 
very short laser pulse (Müller et al. 1991); 2) thermal reactions, where energy of 
laser irradiation is transferred into heat due to the absorption of the photons by 
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tissue components (such as melanin) (Steiner 1993); 3) photobiomodulation, a 
non-thermal-photochemical reactions induced by low light level stimulation of a 
photo-acceptor (Huang et al. 2009).  
Many lines of evidence suggest that red/NIR light delivered at low doses can 
prevent cell apoptosis and improve cell proliferation, migration and adhesion in 
vitro (AlGhamdi et al. 2012; Gao and Xing 2009). A large number of animal and 
clinical studies demonstrated highly beneficial effects of LLLT on a variety of 
diseases. Gundogan et al (2004) reported two successful treatments of AA 
using a 308 nm xenon laser (Gundogan et al. 2004); different light treatments 
have been used to improve both acute (Hopkins et al. 2004) and chronic wound 
healing (Yu et al. 1997).  
The light sources in use in PBM are lasers or light-emitting diodes (LEDs). Both 
light sources are used in clinical practice and demonstrate successful results 
(Karu 2011; Sazonov et al. 1985). A laser emits light through a process of 
amplification by stimulated emission of photons: characteristics of the laser 
emitted light are spatial and temporal coherence (Paschotta 2008). This 
property is intrinsic of the light emission process and is derived by the fact that 
emitted photons are in phase. Spatial coherence allows for a small beam 
divergence of a moderately sized beam, temporal coherence is expressed as a 
narrow optical spectrum or a quasi-monochromatic emission (Paschotta 2008). 
An LED is a semiconductor light source that emits non-coherent light across the 
visible, ultraviolet and infrared wavelengths (Chung et al. 2012).In PBM lasers 
and LEDs have been used with the following range of optical parameters: 1) 
wavelength, between 390-1100 nm that can be continuous wave or pulsed (Avci 
et al. 2013; Hamblin and Demidova 2006); 2) dose or radiant exposure in the 
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range of 1-100 J/cm2 with variable wavelength (Avci et al. 2013; Mignon et al. 
2016a); 3) irradiance covering two orders of magnitude (1-100 mW/cm2) (Avci et 
al. 2013; Huang et al. 2009; Mignon et al. 2016a). 
 
Figure 1-5 Light - biological tissue interactions defined by power density 
and exposure time 
Modulation of irradiance (power density) and exposure time of the light source 
triggers different reactions in tissues: photomechanical, photothermal or 
photochemical. The two diagonals show constant radiant exposures at 1 J/cm2 
(lower diagonal) and 100 J/cm2 (upper diagonal). Adapted from  (Boulnois 
1986). 
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1.3.3 Photobiomodulation: mechanisms of action 
In PBM absorbed photons interact with organic molecules or endogenous 
chromophores present in the tissue to trigger biological reactions. The most 
commonly accepted cellular chromophore for photobiomodulation therapy is 
cytochrome c oxidase (COX) (Hamblin and Demidova 2006). 
The pioneering work of Dr Tiina Karu suggested that cytochrome c oxidase 
plays a role of  a light acceptor with absorption bands in red and near-infrared 
(NIR) range (650 – 980 nm) and even higher (about ten times) extinction 
coefficient around 400-500 nm (Karu 1989). Her theory was supported by 
biochemical studies conducted by Passarella and colleagues on the effects of 
HeNe laser treatments on isolated mitochondria (Pastore 2000): after 
discovering an increase in the rate of electron transfer and in H+/e- ratio for 
COX, as a result of irradiation in isolated mitochondria, they also demonstrated 
that changes in COX reactivity are modulated by laser treatment (Pastore et al. 
1995; Pastore et al. 1994). Over the years a majority of the evidence for COX 
as photo-acceptor has come from experiments in neuronal and HeLa cells. 
Functionally inactivated respiratory chains in in vitro neuronal cells were 
partially rescued by light (Karu et al. 2004; Wong-Riley et al. 2005). In HeLa 
cells, absorption spectra obtained for COX in different oxidation states were 
very similar to the action spectra for DNA and RNA synthesis rate and for cell 
adhesion after light irradiation (Karu and Kolyakov 2005). Photons interacting 
with COX are thought to trigger the increase of ATP via a proton gradient (Karu 
1999). The process involves the release of nitric oxide (NO) either via photo-
dissociation from COX (Karu et al. 2005) or via reduction of nitrite to NO COX-
mediated, as shown by Ball et all using a 590 nm LED light (Ball et al. 2011). 
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The end products of both processes are ATP and ROS, natural by-product of 
the respiration metabolism. Interestingly, ROS can affect the expression of 
genes related to proliferation, migration, cytokines production and growth 
factors, inducing a long lasting effect that is needed for tissue repair (Hawkins et 
al. 2005; Moore et al. 2005; Song et al. 2003). 
Light mediated vasodilation triggered by NO release was first described in 1968 
by Furchgott et al (Ehrreich and Furchgott 1968). Hemoglobin is considered the 
chromophore that supply NO leading to vasodilation (Mittermayr et al. 2007). 
Nevertheless, a recent work reported the presence of Opsin 4 (OPN4) in blood 
vessels and demonstrated that OPN4 mediates wavelength-specific, light-
dependent vascular relaxation (Chaudhry et al. 1993).  
Recent studies have also revealed the existence of a large group or family of 
ion channels called transient receptor potential (TRP) channels. TRP channels 
are ‘cellular sensors’: they respond to environmental stimuli due to changes in 
temperature, stretch/pressure, oxidation/reduction, osmolarity and pH (Kaneko 
and Szallasi 2014) . In insects, TRPV channels are involved in vision (Hardie 
2014) and it has been shown that TRPV are able to respond to green (Gu et al. 
2012) and infrared light (Albert et al. 2012). 
Several aspects are to be taken into account when entering the field of PBM: 
the complexity of a large number of illumination parameters and the biochemical 
mechanisms that are likely to be triggered. A recent review by Mignon et al 
highlighted issues that arose from these uncertainties: reviewing 30 years of 
literature pertaining skin PBM, it was concluded that the range in wavelengths, 
irradiance and radiant exposures used for stimulating skin cells is too wide, and 
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that the presence of several potential photoreceptors in the skin requires further 
examination; finally neither of the mechanisms triggered by light provide a 
convincing explanation for all the physiological effects observed (Mignon et al. 
2016a). 
Thus, a pressing need remains to identify the potential molecular mediators of 
these processes, and subsequently their mode of action. 
 
1.4 Light-sensitive receptors in skin 
In recent years, several molecules have emerged as novel mediators of light 
activation in non-photosensitive tissues, such as nitrosated proteins regulating 
nitric oxide (NO) and the ﬂavoprotein-containing cryptochromes that are also 
involved in the regulation of the circadian rhythm, as well as Opsin receptors. 
 
1.4.1 Opsins and the visual functions 
Opsins are 30- to 40-kDa proteins. They belong to the G-protein-coupled-
receptors (GPCR) protein family, seven helix transmembrane receptors, which 
activate heterotrimeric GTP-binding proteins after photochemical activation of 
the retinaldehyde chromophore, covalently linked to the apoprotein. Opsins can 
be divided into two sub-families (Table 1): 1) visual Opsins, including Opsin 1 
(short, middle and long wavelength), a colour vision mediator found in cone 
cells, and Opsin 2 (Rhodopsin), a dim-light vision mediator that is expressed in 
rod cells; 2) non-visual Opsins, including Opsin 3 (Panopsin or Encephalopsin), 
Opsin 4 (Melanopsin) and Opsin 5 (Neuropsin) (Terakita 2005). Peak of 
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absorption for each of mentioned Opsins is reported in Table 1. However, it 
must be noted that the exact range of the absorption band for both, OPN 2 and 
OPN 3, depends on the amino-acid sequence, the type of retinal bound (7- 9-
cis, 11-cis, 13-cis) (Sekharan and Morokuma 2011), and also on dark versus 
light conditions (Menon et al. 2001). The respective spectral sensitivity of OPN2 
through animal kingdom covers an extremely broad range of the sunlight 
spectrum from 358 nm (near ultraviolet, UVA) to 630 nm (red) (Luck et al. 
2012). OPN3 is a bi-stable pigment absorbing in the region of 400-530 nm, 
generating a stable photoproduct and reverting to its original state upon 
subsequent light absorption rather than undergoing photobleaching (Koyanagi 
et al. 2013). 
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Table 1. Summary table of Opsin family receptors. Colors represent the 
wavelength of absorption peaks for each member of the Opsin family in the 
visible spectrum. 
Photoreceptors 
(λ max) 
Functions Site of Expression  
OPN5 
Non visual opsin; G protein 
coupled receptor; putative 
photoisomerase activity 
(convert all-trans-retinal into 
11-cis 
isomer in a light-dependent 
manner) 
Brain, spinal cord, retina 
(Terakita 2005) 
Neuropsin 
Melanocyte and 
keratinocyte 
(Haltaufderhyde et al. 
2015) 
(380 nm)  
OPN1 
Visual opsin; G protein 
coupled receptor, trigger Gt 
pathway; bind chromophore 
11-cis-retinal; induce 
phototransduction  in color 
vision 
Cones from the outer 
human retina (Terakita 
2005) 
Short wavelenght 
Melanocyte and 
keratinocyte 
(Haltaufderhyde et al. 
2015) 
(420 nm) 
Epidermis upper layer 
(Tsutsumi et al. 2009) 
OPN4 Non visual opsin; G protein Ganglion and amacrine 
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coupled receptor, Trigger Gq 
pathway 
cell layers of the retina 
(Terakita 2005) 
Melanopsin 
(470 nm) 
Melanocyte 
(Haltaufderhyde et al. 
2015) 
 
 
OPN3 
Non visual opsin;  G protein 
coupled receptor 
Brain, testis, liver, 
placenta, heart, lung, 
skeletal muscle, kidney, 
and pancreas (Terakita 
2005) 
Encephalopsin 
(480/500 nm) 
Melanocyte and 
keratinocyte 
(Haltaufderhyde et al. 
2015) 
  
OPN2 
Visual opsin for dim-light G 
protein coupled receptor, 
trigger Gt pathway; bind 
chromophore 11-cis-retinal 
via K296 aa; induce 
phototransduction. 
Disc membranes in the 
outer segment of rod 
photoreceptor cells 
(Terakita 2005) 
Rhodopsin 
Melanocyte and 
keratinocyte 
(Haltaufderhyde et al. 
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2015) 
(500 nm) 
Epidermis upper layer 
(Tsutsumi et al. 2009) 
OPN1 
Visual opsin, induce 
phototransduction in color 
vision; G protein coupled 
receptor, trigger Gt pathway; 
bind chromophore 11-cis-
retinal. 
Cones from the outer 
human retina (Terakita 
2005) 
Middle wavelenght 
Epidermis basal layer 
(Tsutsumi et al. 2009) 
(530 nm)  
OPN1 
Visual opsin, induce 
phototransduction in color 
vision; G protein coupled 
receptor, trigger Gt pathway; 
bind chromophore 11-cis-
retinal. 
Cones from the outer 
human retina (Terakita 
2005) 
Long wavelenght 
Epidermis basal layer 
(Tsutsumi et al. 2009) 
(560 nm)  
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OPN2 has been the most extensively studied Opsin: bovine OPN2 was the first 
to be crystallized (Okada et al. 2000) allowing accurate structure-function 
studies. Similar to others GPCR OPN2 is characterized by phosphorylation sites 
at Ser and Thr residues in the carboxy-terminal tail, although its special feature, 
as visual pigment, is the presence of a retinal chromophore covalently linked 
(Rando 1996). 11-cis-retinal (11-cis-RAL) is the chromophore linked via a 
protonated Schiff base bond to a specific Lysine residue in the membrane 
embedded domain of OPN 2 apoprotein (Menon et al. 2001). Photon capture 
leading to photoisomerization of the 11-cis- to all-trans-form of the RAL 
chromophore is the primary event in visual signal transduction, and it is the only 
light-dependent step (Menon et al. 2001). After photoisomerization, OPN2 
decays thermally to metarhodopsin II (meta-II), the active form of the receptor, 
which catalyzes guanine nucleotide exchange by the rod cell heterotrimeric G 
protein transducin (Gt ) (Menon et al. 2001). In the case of the vertebrate visual 
system, Gt activation leads to the activation of a cGMP phosphodiesterase and 
the closing of cGMP-gated cation channels in the plasma membrane of the rod 
cell. The cascade causes a graded hyperpolarization of the rod cell (Menon et 
al. 2001).   
Restoration of the photosensitive receptor conformation in the eye requires the 
formation of the 11-cis-RAL chromophore from the all-trans-retinal (at-RAL) via 
the retinoid cycle that mainly occurs within the specialized retinal pigment 
epithelial cells (RPE) (Blomhoff and Blomhoff 2006). The entire cycle in humans 
occurs on a time scale of minutes for OPN 2. After photon-induced 
isomerization of 11-cis-RAL to at-RAL, the reduction to all-trans retinol (at-ROH) 
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takes place in rod cells outer segments. All other reactions that leads to 
restoration of 11-cis-RAL occur within RPE (Baehr et al. 2003).  
Relevant reactions of the visual cycle are represented in Figure 1-6. All-trans 
retinyl esters (at-RE) are mobilized by the retinoid isomerohydrolase (RPE65): 
interestingly high doses of 13-cis retinoic acid, that are used in the treatment of 
cancer and acne, can inhibit the visual cycle function, due to competition of the 
retinoic acid with at-RE to RPE65 (Gollapalli and Rando 2004). Also retinol 
dehydrogenase 5 (RDH5) and 11 (RDH11) knock-out mice show minor 
modifications in dark adaptation (Kasus-Jacobi et al. 2005; Kim et al. 2005). 
These evidences are consistent with a role for those enzymes in the visual 
cycle.  
Figure 1-6 The visual cycle in human.  
The figure shows 
main reactions 
within the visual 
cycle in human 
retina. All-trans-
retinal (at-RAL), 
all-trans-retinol (at 
ROH), short-chain 
dehydrogenase/reductase (SDR). lecithin:retinol acyl transferase (LRAT), 
isomer-hydrolase (RPE65), 11-cis retinol (11-cis ROH), interstitial retinoid-
binding protein (IRBP) (Blomhoff and Blomhoff 2006). 
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1.4.1.1 Opsin alternative pathways in the skin  
Recent studies have revealed that the distinct members of the Opsin family are 
present in human skin and could contribute to skin homeostasis (Tsutsumi et al. 
2009). For example, OPN2 expression was found in both human epidermal 
keratinocytes and melanocytes (Wicks et al. 2011). A single exposure to violet 
light (380 – 410 nm) activated OPN2 and suppressed keratinocyte 
differentiation (Kim et al. 2013b). In human melanocytes, OPN 2 was found to 
contribute to photo-transduction of ultraviolet A radiation (UVA) to increase 
melanin synthesis (Wicks et al. 2011). OPN 3 expression was found in the 
retina, as well as in the cells outside of visual system, which suggests that OPN 
3 might function as a photoreceptor in various tissues (Halford et al. 2001; 
White et al. 2008). Interestingly, a homolog of the vertebrate OPN 3 maintained 
photosensitive properties in vitro after transfection in mammalian cells, 
suggesting that OPN3 homologs might have the same ability to bind the non-
conventional isomer 13-cis retinal to form an active photopigment (Koyanagi et 
al. 2013; Sugihara et al. 2016).  
 
1.4.2 Cryptochrome and clock genes 
Cryptochromes belong to the photolyases family of photoreceptors that respond 
to blue light. Photolyases are enzymes that utilize light energy to repair UV-
damaged DNA, while Cryptochromes lack this enzymatic activity and function 
as signaling molecules that respond to blue light in plants (Chaves et al. 2011). 
Structurally, Photolyases and Cryptochromes are very similar; they both share 
two chromophores at the N-terminal region, a pterin and a flavin domain, while 
the C-terminal domains are variable in length and poorly conserved (Chaves et 
38 
 
al. 2011). Blue-light dependent photoactivation is a common reaction, also to 
human Cryptochromes, involving electron transfer and flavin reduction 
(Cashmore et al. 1999; Hoang et al. 2008). It has recently been demonstrated in 
plants that Cryptochrome activation via flavin photoreduction is a reversible 
mechanism novel to blue light photoreceptors: Cryptochromes activation by 
blue light (420-480 nm) was inhibited by green-yellow light (550-600 nm). This 
photocycle may have adaptive significance for sensing the quality of the light 
environment in multiple organisms (Bouly et al. 2007; Giovani et al. 2003).  
The accepted definition of Cryptochrome is a protein with similarity to 
photolyases that has lost or has a reduced DNA repair activity and has gained a 
novel role in signaling (Chaves et al. 2011). Two human genes with high degree 
of sequence homology to the blue light photoreceptors present in plants were 
discovered in 1996 (Hsu et al. 1996). The two human Cryptochrome 1(CRY1) 
and Cryptochrome 2 (CRY2) are 73% homologous to each other, but exhibit no 
sequence homology within the C-terminal 75 amino acids (Lin and Todo 2005). 
It is thought that this domain may bind to effector molecules (Lin and Todo 
2005). The hCRY1 protein is 586 amino acids in length and encodes a protein 
of 66 kDa. The hCRY2 protein is 593 amino acids in length and has a mass of 
67 kDa (Hsu et al. 1996).  
Mammalian Cryptochromes are integral components of the circadian clock, an 
endogenous timekeeper that generates rhythms in behavior, physiology, and 
metabolism with a periodicity of approximately 24 hours; the rhythm generated 
by the molecular machinery will be discussed later. The suprachiasmatic 
nucleus (SCN) of the hypothalamus is considered as the master clock: the SCN 
receives external cues (or zeitgeber, from German zeit = time and geber = 
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giver) such as light and dark cycles, detected by eye, and synchronises the 
circadian activity of the molecular clock found in peripheral tissues, which 
consist in auto-regulatory feed-back loops. This synchronization is directed by 
the SCN by rhythmic expression of hormones (prolactin, cortisol) that influences 
activity of multiple organs (Golombek and Rosenstein 2010; Sancar 2000). 
However, the role of the central clock has been challenged in recent years by 
the discovery of self-sustained oscillations in several tissues throughout the 
body, which might be particularly relevant for local rhythmic events (Golombek 
and Rosenstein 2010; Kowalska and Brown 2007).  
Mammalian Cryptochromes participate in the regulation of the molecular clock 
at cellular levels. A first classification identified two types of Cryptochromes. 
Type I Cryptochrome is light responsive and acts as circadian photoreceptor, as 
in Drosophila and other insects. Type II was considered to be light-irresponsive, 
with a transcription-repressing activity, as in mouse, human, and other 
vertebrates (Chaves et al. 2011). However, several studies demonstrated the 
light-dependent functions of mammalian CRY proteins: knockout mice lacking 
one or both Cry genes have a reduced or abolished ability to induce expression 
of genes such as Period (Per) and the proto-oncogene c-fos in response to light 
(Selby et al. 2000; Thresher et al. 1998). Moreover, the pupils of mutant mice 
lacking both Cry1 and Cry2 have reduced reflex responses to light (Van Gelder 
et al. 2003), and even if Cry1/Cry2 double mutant mice show an apparently 
normal rhythmicity in light-dark cycling conditions, they lose rhythmicity 
instantaneously and completely in “always dark” conditions (Van Der Horst et al. 
1999). Interestingly, mice with retinal degeneration preserve the ability to 
respond to light-dark cycles, unless not only Opsins receptors but also 
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Cryptochromes are ablated, suggesting that Opsins and Cryptochromes 
photoreceptors may share functionally redundant roles in the transduction of 
light information (Selby et al. 2000). In particular, Cryptochromes may play both 
roles: acts as photoreceptors and mediate the activity of circadian clock. 
 
1.4.2.1 Molecular mechanisms of the circadian clock 
Circadian rhythms produce oscillations at the molecular, physiological and 
behavioral levels in organisms with periodicity of 24 hours, as a consequence of 
exposure to daily light-dark cyclic variation. Circadian rhythms are observed in 
all animal species and are synchronized with the environment by light. In 
mammals light is absorbed by Opsins located in the outer retina of eye for 
vision. In mice has been described a specific localization of Cryptochromes in 
the ganglion cells and the inner nuclear layer of the retina, leading to the 
hypothesis that these molecules can be the photo-acceptors of light for 
synchronizing the circadian clock (Sancar 2000). The mammalian circadian 
system is organized in a hierarchy of oscillators: at the top of the master 
“synchronizer” is the SCN, anatomically localized in neuron clusters in the 
anterior hypothalamus (Yamazaki et al. 2000). For long time it was commonly 
thought that peripheral circadian regulation was only governed by 
neuroendocrine mediators released by the SCN, as emerged by arrhythmic 
behavior and abolished Per2 expression in rats having SNC lesions (Sakamoto 
et al. 1998). In recent years it has been not only well established that molecular 
oscillators are present in every tissue and cell types, including the skin (Brown 
et al. 2005; Zanello et al. 2000), but also that organs like the liver, heart and 
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kidney have peripheral molecular clock activity that oscillate irrespective of the 
central pacemaker (Sato et al. 2014; Schmutz et al. 2012; Yoo et al. 2004). 
In mammals, the circadian molecular machinery is cell autonomous and 
consists of a network of transcriptional and translational feedback loops that 
drive expression of clock components (Buhr and Takahashi 2013; Ko and 
Takahashi 2006). The transcriptional activators Clock Circadian Regulator 
(CLOCK) and the Brain and Muscle ARNT-Like (BMAL) proteins are at the core 
of the oscillator: the two transcription factors heterodimerize and bind to E-box 
elements to induce transcription of CRY and PER genes. Once the products 
accumulate in the cytoplasm, PER and CRY can dimerize and translocate into 
the nucleus where they inhibit their own expression, acting on the CLOCK-
BMAL complex (Buhr and Takahashi 2013; Ko and Takahashi 2006). Once 
CLOCK-BMAL1 complex is formed, the second feedback loop is initiated, 
inducing the transcription of the Retinoic Acid-Related Nuclear Orphan 
Receptor, Rev-Erbα and Rorα genes: the two proteins compete for the retinoic 
acid-related Orphan receptor Response Element (RORE) binding sites within 
the promoter of BMAL1, where RORα and REV-ERBα proteins initiate and 
inhibit Bmal1 transcription respectively (Ko and Takahashi 2006). The auto-
regulatory feedback loops described takes almost 24 hours to complete a cycle 
and constitute the circadian molecular clock (Figure 1-7) (Ko and Takahashi 
2006). 
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Figure 1-7 Network of the mammalian molecular clock 
Autoregulatory feedback loops: Generation of the 24 hours molecular clock is 
governed by post-translational modifications such as phosphorylation and 
ubiquitination of clock proteins. These processes affect the stability and nuclear 
translocation of core clock proteins as PER and CRY. Casein kinase 1 epsilon 
and Casein kinase 1 delta (CK11 and CK1d) mediates the critical aspect of 
protein phosphorylation (Ko and Takahashi 2006) 
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1.4.2.2 Role of the molecular clock in hair follicles 
Genes whose expression is regulated by clock transcription factors are largely 
tissue and cell specific (Balsalobre et al. 1998; Storch et al. 2002). It has 
recently emerged that the peripheral clock machinery can regulate physiological 
functions in the skin (Al-Nuaimi et al. 2014; Plikus et al. 2013). In vivo (Plikus et 
al. 2013; Tanioka et al. 2009) and in vitro (Al-Nuaimi et al. 2014) studies 
demonstrated that HFs present a robust molecular clock that play a role in hair 
cycle regulation. 
An important aspect emerging from studies on mice is the compartmentalization 
of clock activity over time: circadian genes are robustly expressed in hair germ 
progenitors during telogen and the telogen-to-anagen transition (Lin et al. 
2009). In contrast, CLOCK (Al-Nuaimi et al. 2014; Plikus et al. 2013) and clock 
output genes (Lin et al. 2009) are most highly expressed in the matrix and DP 
cells during anagen phase (Plikus et al. 2013). Furthermore, although all of the 
core clock genes are expressed in telogen and anagen skin, only about 6% of 
clock-regulated genes overlap between these two phases of the hair growth 
cycle (Geyfman et al. 2012a). It is possible that the peculiar distribution of clock 
genes during different phases of the cell cycle leads to differential expression of 
circadian regulated genes. In mice deletion of Bmal1 leads to a delay in anagen 
initiation (Lin et al. 2009). Double Cry1/Cry2 deletion alters the daily mitotic 
rhythm of hair matrix cells (Plikus et al. 2013), suggesting a role for the 
circadian clock machinery in regulation of hair cycle in mice. 
Recent studies has confirmed that clock activity in human HF is similar to that of 
mice and that clock elements are present in all compartments of the HF (Al-
Nuaimi et al. 2014; Hardman et al. 2015). Robust circadian activity in human 
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HFs is maintained in vitro in the absence of synchronizing inputs from the CNS. 
Furthermore, downregulation of BMAL1 or PER1 leads to the prolonged growth 
of HF in culture and their hyperpigmentation (Al-Nuaimi et al. 2014; Hardman et 
al. 2015).  
Taken together, the circadian clock plays the important role in mediating cell 
proliferation and in hair growth control. However, if Cryptochromes could 
directly mediate effects of light in the HF is largely unknown.  
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1.5 Aims and Objectives 
Though devices for hair growth based on low levels of light have shown 
encouraging results, further improvements of their efficacy is impeded by a lack 
of knowledge on the exact molecular targets that mediate physiological 
response in skin and hair follicle. The objective of this study was to identify the 
expression of light-sensitive receptors in the human hair follicle that could 
mediate the positive effect of UV-free blue light on hair growth. 
The following specific aims will be addressed: 
1) To determine the presence of light-sensitive receptors and define their 
localization in specific hair follicle compartments: the expression of 
Cryptochromes and Opsins will be evaluated in human full-thickness skin and 
micro-dissected anagen hair follicles by employing qPCR and 
immunofluorescence analysis  
2) To determine the functional significance of the identified receptors in hair 
growth control; the effects of gain- or loss-of function of the selected receptors 
on hair growth ex-vivo and on the activity of primary hair follicle cells will be 
assessed using chemical or RNA interference approach  
3) Light treatment will be performed on hair follicle ex-vivo and on primary hair 
follicle cells to evaluate effect on hair growth and proliferation: UV-free blue light 
is selected because highly absorbed by investigated light receptors.  
4) To assess if positive effect of light on hair growth could be mediated by the 
selected light-sensitive receptors the hair follicles ex vivo and hair follicle cells 
will be co-treated with light and corresponding siRNAs.  
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2 Material and Methods 
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2.1 Human skin and hair follicle collection 
The present project was run in two countries UK and Netherlands. Tissue 
supply was arranged as follow: in Bradford (UK) human scalp skin was obtained 
from the occipital regions from female or male donors undergoing elective 
cosmetic surgery from the Farjo medical centre (Manchester, UK).Tissue was 
obtained with full written consent adhering to the Declaration of Helsinki 
principles and following institutional approval from the University of Bradford, 
under human tissue act guidelines. For the work performed at Philips Research 
(Eindhoven, Netherlands) HFs were isolated from the temporal or beard region 
of fresh surplus residual facial skin within 8 hours of surgery. Human skin was 
obtained after facelift surgery from healthy donors adhering to the Declaration of 
Helsinki principles under Human Tissue Transfer Agreement, between Philips 
Electronics Nederland B.V. acting through Philips Research and corresponding 
clinics, where clinics were responsible for obtaining written informed consent 
from all patients. All experimental protocols were approved by the Philips 
Internal Committee of Biomedical Experiments (ICBE), DocSet ID ICBE-2-6171. 
Philips Electronics Nederland B.V., acting through Philips Research Eindhoven, 
confirms that it was its responsibility to ensure that approvals by appropriate 
local and/or national Ethics Committees and relevant authorizations were 
obtained whenever such approvals were required for the experiments. In the 
Netherlands, collection and use of human tissue for scientific research is 
regulated via Article 467 of the Medical Treatment Contracts Act (Wet op de 
geneeskundige behandelingsovereenkomst, WGBO).  
A list of donor samples employed for the experiments is reported in the Table 2.  
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Table 2: A list of donor samples employed for the experiments in the 
project 
Subject 
ID 
Age Sex Body 
location 
Model Experiment Country 
1 42 M occipital HFs KL001 treatment UK 
2 46 F temporal HFs KL001 treatment Netherland 
3 51 M occipital HFs KL001 treatment UK 
4 65 F temporal HFs KL001 treatment Netherland 
5 41 M occipital HFs CRY1 silencing in 
HFs 
UK 
6 55 F temporal HFs CRY1 silencing in 
HFs 
Netherland 
7 46 M occipital HFs CRY1 silencing in 
HFs 
UK 
8 43 F occipital HFSC cell sorting UK 
9 70 F occipital HFSC cell sorting UK 
10 66 F occipital HFSC cell sorting UK 
11 55 F temporal ORS RNA and IF Netherland 
12 58 F temporal ORS RNA and IF Netherland 
13 68 F temporal ORS RNA and IF Netherland 
14 53 F temporal ORS siCRY1 Netherland 
15 54 F temporal ORS light tx,siOPN3 Netherland 
16 
 
55 F temporal ORS light tx,microarray, 
siOPN3 
Netherland 
17 56 F temporal ORS light tx, siOPN3 Netherland 
18 65 F temporal ORS siCRY1 Netherland 
19 69 F temporal ORS light tx, microarray, 
siCRY1 
Netherland 
20 - F temporal HFs HFs and light Netherland 
21 55 F temporal HFs HFs and light Netherland 
22 - F temporal HFs HFs and light Netherland 
23 - F temporal HFs HFs and light Netherland 
24 - F temporal HFs HFs and light Netherland 
25 - F temporal HFs HFs and light Netherland 
26 - F temporal HFs HFs and light Netherland 
27 53 F temporal HFs HFs and light Netherland 
28 67 F occipital full 
thickness 
skin 
IF UK 
29 46 F occipital full 
thickness 
IF Netherland 
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skin 
30 60 F occipital full 
thickness 
skin 
IF UK 
31 46 M beard full 
thickness 
skin 
IF UK 
32 - M beard full 
thickness 
skin 
IF Netherland 
 
2.2 RNA extraction and cDNA synthesis 
Total RNA was isolated from either microdissected HFs or primary HF 
keratinocytes. Microdissected HFs were collected in 1 ml of TRIzol® (Life 
Technologies), mechanically homogenised with a pestle and optionally stored at 
-80°C. Primary ORS cells lysate was collected in 300 µl TRIzol® (Life 
Technologies), vortexed for few seconds and optionally stored at -80°C. RNA 
isolation was performed using the spin column kit Direct-zol™ RNA MiniPrep 
(Zymo research) following manufacturer’s protocol.  
Briefly, an equal volume of 100% ethanol was added to a sample lysed in 
TRIzol® (Life technologies) and mixed thoroughly. The mixture was transferred 
into a Zymo-Spin™ Column. All centrifugations were performed at room 
temperature (RT) at 13000 x g for 30 seconds using a bench centrifuge 
(Eppendorf), except were indicated differently. 400 µl of RNA Wash Buffer 
solution were added to the column and centrifuged. DNase I treatment was 
performed in column by incubating with the digestion mix, prepared as follow: 5 
µl DNase I (6 U/µl) and 75 µl DNA Digestion Buffer (15 minutes, RT). Next, 400 
µl of Direct-zol™ RNA PreWash buffer were added to the column and 
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centrifuged followed by adding 700 µl of RNA Wash Buffer to the column and 
centrifugation for 2 minutes. Finally, the column was carefully transferred into an 
RNase-free tube. To elute RNA 50 µl of DNase/RNase-Free Water was added 
directly to the column and centrifuged at maximum speed for 30 seconds. 
Extracted total RNA was either stored at ≤-80°C or used for further analysis. 
First strand cDNA synthesis was performed using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems™). Random primers were used; 
manufacturers’ protocol was followed for 2X master-mix preparation. 100 ng of 
RNA were added to 10 µl of 2X master-mix in each tube. cDNA was 
synthesized using a Master Cycler gradient machine (Eppendorf) under the 
following cycling conditions: 25°C for 10 minutes, followed by 37°C for 120 
minutes and 85°C for 5 minutes. 
 
2.3 RT-PCR  
Primers listed in Table 3 were used for PCR amplification of the region 
corresponding to the retinal-binding site of human Opsins 1,3,4 and 5 
(Haltaufderhyde et al. 2015). OPN2 and CRY1 primers targeting the 3’UTR 
region of the transcript were employed. 
Table 3 RT-PCR primer sequences 
Accession 
Number 
Gene Sense/anti-sense primers 
Source 
NM_001708 
Opsin 1 short 
wavelength 
(OPN1sw) 
F:GTGGGGCCGTGGGATGG
GCCTCAGTACCAC 
R:CCTCAGTTGGGGCCAAC
TTGGGTAGACGAGACAG 
(Haltaufderhyd
e et al. 2015) 
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NM_020061 
Opsin 1 
middle-long 
wavelength 
(OPN1) 
F:GGARGTGASSCGCATGG
TGGTKGTGATG 
R:TCATGCAGGCGATACCG
AGGACACAGATGAGAC 
(Haltaufderhyd
e et al. 2015) 
NM_000539 
Rhodopsin 
(OPN2) 
F:TATAGAATGGGGCACACA
GTAGG 
R:TATAGTCTGATGACTGCA
TTCTGC 
New Design 
NM_014322 
Encephalopsin 
(OPN3) 
F:GGTCATGGTCACCTGGTC
ACTCCAACAATATC  
R:CCTGTCCCCATCTT 
TCTGTGACATCACAATGG 
(Haltaufderhyd
e et al. 2015) 
NM_001030
015 
Melanopsin 
(OPN4) 
F:ACTCAGGATGAACCCTCC
TTC 
R:TGAACATGTTGGCAGGTG
TC 
(Haltaufderhyd
e et al. 2015) 
NM_181744 
Neuropsin 
(OPN5) 
F: 
TTCAGATCCCTCGTGGTTC
GAGAACAGA 
R:GCAAGCCGTTCACCATCA
TCTCTTGCTTTTGTCAC 
(Haltaufderhyd
e et al. 2015) 
NM_004075 
Cryptochrome 
1 (CRY1) 
F:ATATGGGTCAACAAGTTT
GGGATC 
R: 
ATATGCTTCCAAGAGAATTG
CCTC 
New Design 
 
For the amplification reaction GoTaq® DNA Polymerase 1,25 u (Promega) has 
been mixed with 0,2 µM each dNTPs, 1µM of forward and reverse primers in 1x 
Reaction buffer, water up to 20 µl final volume. The amount of cDNA required 
for the amplification reaction was optimized for each primer set. Amplification 
was performed using the touchdown PCR protocol for OPN1, 3, 4 and 5 primers 
as described by Haltaufderhyde et al, (Haltaufderhyde et al. 2015). For OPN2 
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amplification, standard PCR conditions were employed: 95°C for 2 min, followed 
by 34 cycles of denaturation (95°C for 20 s), annealing (51°C for 20 s), and 
elongation (72°C for 30 s). Total RNA from the human eye (Amsbio) and from 
HaCaT cell lines was used as positive control.  
For DNA detection agarose gel was prepared mixing 1.2% (w/v) Agarose (Gene 
Flow) in 1x TBA Buffer in a Erlenmeyer flask. The agarose/buffer mix was 
heated in a microwave for 30 seconds or until agarose has completely 
dissolved. After cooling the gel mixture Ethidium Bromide at a concentration of 
10 µg/ml (Invitrogen) was added to the solution. Samples and High Ranger Plus 
100bp DNA ladder (Norgen) were loaded in the gel solidified in electrophoresis 
chambers (Fisher brand). The PCR products were run under 90V (Bio-Rad's 
PowerPac™ power supplies) for 40 minutes; products size have been 
evaluated under a UV lamp (Ingenius Sungene BioImaging). Images were 
acquired using Gene Snap (SynGene) software. 
2.4 RT-qPCR 
RT-qPCR was performed using Applied Biosystems Fast PCR mix, using 10ng 
cDNA and 1μM primers. PCR primers used for qPCR are listed in Table 4. 
Table 4 RT-qPCR primer sequences 
Accession 
Number 
Gene Sense/anti-sense primers 
Ann. T 
(°C) 
NM_004075 CRY1 
F:AGGAGAACCACGACGAGA 
R:TCCGCTTCACCTTTTTATAC 
61 
NM_001127457 CRY2 
F:TGGTGGTTGTGATGGTAGGA 
R:ATGCAAGTTGGAACTGCTT 
61 
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NM_014322 OPN3 
F:AGGAACACGAGGATTCTTGC 
R:GCGAGGGTCTGAGAGGATAG 
61 
NM_000539 OPN2 
F:ACCCCACTCAGCATCATCGT 
R:CCAGCAGAAGCAGAATGCCAGGAC 
62.2 
NM_002616 PER1 
F:TGGCTATCCACAAGAAGATTC 
R:GGTCAAAGGGCTGGCCCG 
61 
NM_022817 PER2 
F:TCCAGATACCTTTAGCCTGATGA 
R:TTTGTGTGTGTCCACTTTCGA 
61 
NM_001289861 PER3 
F:CCCCTCTCTGTCCTCTGTTG 
R:ACTGCCATTGTTGCCTGTAA 
61 
NM_001267843
.1 
CLOCK 
F:TTGTAAGCTGCCTGGGTTTC 
R:CTCAGTGTTTGCTGGTGGTG 
61 
NM_001030272
.2 
BMAL1 
F:AAACCAACTTTTCTATCAGACGATGAA 
R:TCGGTCACATCCTACGACAAAC 
61 
NM_000526 K14 
F:GCCTGTCTGTCTCATCCTC 
R:CTGAAGCCACCGCCATAG 
62 
NP_002266.2 K15 
F:AAAGAAGTGGCCTCCAACACA 
R: TCTCGGCCAGTGAGTTCTCC 
62 
NP_001004196 CD200 
F:TGTTACATGTGTCTCTTCA 
R: AGTGGCAGAGCAAGTGATAT 
59.8 
NP_001020280 CD34 
F: CTACAACACCTAGTACCCTTGGA 
R: GGTGAACACTGTGCTGATTACA 
62 
NM_025218 ULBP1 
F:AAGGCCTGGTGGATGAAAGG 
R: CAGGGTGAGGGGCTCAATG 
62,5 
NM_007085 FSTL1 
F:GAGCAATGCAAACCTCACAAG 
R:CAGTGTCCATCGTAATCAACCTG 
62,5 
NM_022754 SFXN1 
F:TTCAATGCCGTCGTCAATTACA 
R:CGTAAGCTGTTCCCAACTCAT 
62,5 
NM_001206747 CAV2 F:AAGACCTGCCTAATGGTTCTGC 62,5 
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R:CTCGTACACAATGGAGCAATGAT 
NM_002577 PAK2 
F:CACCCGCAGTAGTGACAGAG 
R:GGGTCAATTACAGACCGTGTG 
62,5 
NM_015902 UBR5 
F:GTCCATCCATTTCGTGGTTCA 
R:CCAATTCCAATCTGTCTGGCTG 
62,5 
NM_001001342 
BLOC1
S2 
F:CAAGTGGAGGGATGTCGGAA 
R:GTCTTCACTGGTGGCCGT 
62,5 
NM_001008895 CUL4A 
F:AGCAGCACCTCCATCAGGTA 
R:TCCTGCCAGCACGTGTTAAT 
62,5 
NP_003208 TMBIM6 
F:CATATAACCCCGTCAACGCAG 
R:GCAGCCGCCACAAACATAC 
60,1 
NP_002799 PSMD2 
F:TGCTCGTGGAACGACTAGG 
R:CAGTTTGCCATAGTGTGGACG 
60,1 
NP_006792 
KDELR
1 
F:TCAAAGCTACTTACGATGGGAAC 
R:ATTGACCAGGAACGCCAGAAT 
60,1 
NP_001138778 CDK6 
F:TCTTCATTCACACCGAGTAGTGC 
R:TGAGGTTAGAGCCATCTGGAAA 
60,1 
NP_057529 PLEK2 
F:CCGAAGCATGGGAGCCATT 
R:AGTGCTCAGGCTAATTTCTTCC 
62,5 
 
All primers were optimised using Human Universal reference cDNA (Clontech) 
at different temperatures: 58°C, 61°C, 62°C and 64°C. Analysis of melting 
curves was used to determine optimum annealing temperature.  
Amplification was performed using StepOnePlusTM real-time PCR system 
(Applied Biosystems) and following conditions: 
Stage Temperature Time Cycles 
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Initial Denaturation 95°C 20 seconds  
Amplification cycles : 
Denaturation 
95°C 3 seconds 
40 
Annealing 
Table 4 RT-
qPCR primer 
sequences 
30 seconds 
Elongation 95°C 15 seconds 
  
After amplification, a melting curve was created by gradually heating the PCR 
products from 65°C to 90°C. For each gene of interest, RT-qPCR was 
performed in duplicates. The differences between samples and controls were 
calculated using the GenexTM software (Bio-Rad) based on the Ct (Ct
∆∆) 
equitation method and normalized to the housekeeping GAPDH gene.  
 
2.5 Tissue processing 
Depending on the experimental design either microdissected HFs or full 
thickness skin were placed in OCT embedding medium (Thermo-scientific), 
snap frozen in liquid nitrogen and stored at -80ºC. Subsequently, 6 μm 
thickness cryosections of OCT embedded HFs or full thickness skin were cut 
using a cryostat (Cryotome™ FSE Cryostats, Thermo Scientific) and mounted 
on glass microscope slides (Superfrost+, Thermo-scientific). 
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2.6 Immunofluorescence 
HF or skin cryosections were briefly air-dried followed by fixation step in 
acetone (10 minutes, -20°C) or in 4% paraformaldehyde (PFA) (10 minutes, RT) 
(Thermo-Fisher Scientific) depending on primary antibodies used (Table 5). An 
additional permeabilization step in 0.1% Triton X100 for the detection of nuclear 
antigens was performed. The tissue sections were incubated in 5% BSA 
(Sigma) for blocking of non-specific binding of antibodies. Optimal dilutions for 
primary antibodies were used (Table 5); incubation was performed overnight at 
4°C. Subsequently, sections were incubated with corresponding secondary 
antibodies, Alexa-488 or Alexa-555 or Alexa-647 (Invitrogen) for 1 hour at 37°C. 
Cell nuclei were labelled using VECTASHIELD® mounting medium containing 
DAPI (4', 6-diamidino-2-phenylindole) (Vector Labs). 
TUNEL assay was performed by employing the ApopTag® Fluorescein Direct In 
Situ Apoptosis Detection Kit (Millipore) following manufacturer’s instruction.  
Image acquisition was performed using a confocal microscope (Leica) and a 
fluorescent microscope Nikon Eclipse 501 in combination with DS-C1 digital 
camera and ACT-2U image analysis software (Nikon). 
Table 5 Primary antibodies and dilutions. 
Antigen Host Manufacturer Diluition 
Cryptochrome 1 Mouse Abcam 1:400 
Encephalopsin (OPN3) Rabbit Abcam 1:100 
Rhodopsin, RETP1 clone Mouse SIGMA 1:50 
Keratin-15 Mouse Abcam 1:100 
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CD200 Goat R&D system 1:100 
Hair cortex keratin (AE13) Mouse Abcam 1:100 
Trichohyalin (AE15) Mouse Abcam 1:500 
Keratin 10 Rabbit Abcam 1:200 
Keratin 14 Rabbit Abcam 1:100 
CDK6 Rabbit Abcam 1:500 
 
2.6.1 Image analysis  
Image acquisition was performed using a fluorescent microscope (Nikon Eclipse 
501) and Image Analysis software (ImageJ). For density measurement of the 
immunoreactivity of CRY1 and CDK6 in HFs, images were taken at x20 
magnification and same exposure time in the experimental and control groups. 
Background correction was performed for every image using the “rolling ball” 
algorithm (ImageJ software) by setting the radius to a size that correspond to 
the largest object that is not part of the background. Intensity of 
immunoreactivity in the bulb region was measured by selecting an area of a 
defined size. Means±SD were calculated from pooled data (2-3 donors, 4 HFs 
from each donor) and statistical analysis was performed using Mann-Whitney 
test. 
2.6.2 Quantitative analysis of proliferation and apoptosis (Ki-67/TUNEL 
staining) 
The number of Ki-67 and TUNEL positive cells was counted below Auber’s line 
(the widest part of the DP). The percentage of proliferative and apoptotic cells 
was calculated against the total number of DAPI+ nuclei below this line. 
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Means±SD were calculated from pooled data (2-3 donors, 4 HFs from each 
donor) and statistical analysis performed using Mann-Whitney test. 
 
2.7 Human hair follicle organ culture 
Anagen HFs isolated from the full-thickness skin were microdissected with 
forceps and a scalpel using a stereo microscope. If HFs were collected as 
pilosebaceus units they were trimmed to remove the epidermis, dermis, fat, and 
sebaceous glands. Microdissected HFs we cultured at 37°C in a humidified 
atmosphere of 5% CO2 under serum-free conditions in William’s E medium 
(Thermo Fisher Scientific) supplemented with hydrocortisone 10 ng/ml (Sigma-
Aldrich), L-glutamin 2mM (Sigma-Aldrich), and Penicillin 1000 U/ml / 
Streptomycin 1mg/ml (Sigma-Aldrich), with or without insulin 10 µg/ml (Sigma-
Aldrich), depending on experimental conditions. Under complete conditions 
anagen HF continue to produce a pigmented hair shaft up to 10 days (Philpott 
et al. 1994b).  
 
2.8 CRY1 stabilization with KL001 treatment  
To enhance CRY1 activity in the HF a small molecule, KL001 (N-[3-(9H-
carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)-methanesulfonamide) 
(Sigma) diluted in DMSO (20 mg/ml) was used. In brief, HFs from 4 donors (42-
65 y.o) were micro-dissected and grown in 24 multi-well culture plate, one HF in 
each well. HFs were grown in supplemented William’s E media but without 
insulin, in order to mimic hair growing under impaired conditions. 2,7 and 8 µM 
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KL001 was added to the HF culture media on days 1 and 3. HFs were cultured 
up to 7 days. In the control group 0.01% DMSO was used. Images of the HFs 
were taken at day 0, day 3 and 7 under a stereoscopic microscope at x20 
magnification and a Nikon Coolpix digital camera using the Visicam image 
analysis software to assess HF morphology.  
 
2.9 Silencing of CRY1  
Microdissected cultured anagen HFs (three donors, 41-55 y.o.) were grown in a 
24 multi-well plate, one HF per well in William’s E complete media and 
transfected with a mixture of small interference RNA (siRNA) against Cry1 gene 
(Accell SMARTpool - Human, Dharmacon) and with non-targeting scrambled 
siRNA as a negative control (Accell Non-targeting siRNA- Human, Dharmacon) 
after the 24h equilibration period. Only growing HFs were selected for 
transfection. Accel- modified siRNAs are used without additional transfection 
reagents, virus or instruments, in serum free conditions. siRNA were re-
suspended in complete William E medium at a final concentration of 1 µM for 
the pool of siRNA (siCRY1) or scrambled siRNA and the mixtures were added 
to the cultured HFs. Ninety-six hours after transfection half of the HFs (5-12) 
from each group were collected for RNA extraction to evaluate silencing 
efficiency. The rest of the HFs was embedded in cryomatrix and snap frozen for 
immunohistochemical analysis. Images were taken at day 0, 3 and 4 of the 
experiment using a stereoscopic microscope at x20 magnification equipped with 
a Nikon Coolpix digital camera for morphological evaluation. Images were 
analyzed using the Visicam image software. 
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2.10 Light treatment of HF ex vivo  
Microdissected HFs from 7 donors (53-55 year old) were cultured in phenol red-
free supplemented Williams E medium (Life Technology). Williams E medium 
contains traces of retinol, as specified in the media formulation. Because HF 
cells are known to possess a system for synthesis and metabolism of retinoids 
(McDowall et al. 2008), no cis-retinal was added to the culture medium. HFs 
were cultured at 37°C in a humidified atmosphere of 5% CO2 up to 14 days. 
Light treatment was performed using two proprietary LED-based devices with 
flat homogeneous illumination over the area of the 24-well plate. Each device 
was emitting one discrete wavelength: 453 nm central wavelength,16 nm full 
width half maximum (PHILIPS, The Netherlands) previously used for the 
experiments on in vitro human cells study and in human clinical trials 
(Kleinpenning et al. 2010; Liebmann et al. 2010), and 689 nm central 
wavelength, 24 nm full width half maximum (PHILIPS, The Netherlands). 
Separate groups of HFs were treated daily using 453 nm or 689 nm 
wavelengths, 16mW/cm2 irradiance, 3.2 J/cm2 radiant exposures during 10 
consecutive days. Irradiance and radiant exposure were set to low levels to 
assure initiation of only photobiological effects, avoiding photothermal reactions. 
450 nm wavelength was selected based on absorption spectra of investigated 
receptors, Opsin and Cryptochorme; impact of red light was also evaluated 
because often use for devices for in vivo hair growth stimulation (Lanzafame et 
al. 2013; Lanzafame et al. 2014) .Optical power was measured before each 
experiment using the Nova II power meter (Ophir Optronics Solutions Ltd) at the 
plane of HFs, assuring delivery of the correct irradiance (watts per area). No 
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increase in temperature above 37°C was observed as monitored using FLIR 
A655sc Infrared Camera, (FLIR® Systems, Inc). Culture medium was refreshed 
every other day over the period of light treatment, adapting the protocol of 
Mignon et al (Mignon et al. 2016b). The images were taken with wide-field 
microscope (Leica) for morphological evaluation. For statistical analysis, the 
effects of medium, donor, and light treatments on mean survival time with 
standard errors, were based on a random-effects interval-data regression 
model. A commercial software package was used: StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: StataCorp LP. 
 
2.11  Cell culture and transfection 
Primary human outer root sheath (ORS) keratinocytes were isolated from 
microdissected anagen HFs as described previously (Inoue and Yoshimura 
2013). Briefly, total skin was washed with 1x PBS, hair shafts were shaved and 
subcutaneous fat was removed. The skin was cut into several stripes of 1 mm 
width and incubated with Dispase I (Roche) overnight at 4°C, which allowed 
separating epidermis and the HFs from the dermis using forceps. After removal 
of sebaceous glands HFs were incubated with 0.05% trypsin- 0.02% EDTA at 
37°C for 5 min. Following enzymatic digestion HFs were transferred into a 
solution with 10% FBS in DMEM to neutralize trypsin. Cells were filtered 
through a 40 um nylon mesh filter, pelleted by centrifuging at 170 g for 5 
minutes and re-suspended in Keratinocyte Growth Medium 2 supplemented 
with Bovine Pituitary Extract 0.004 ml / ml, Epidermal Growth Factor 
(recombinant human) 0.125 ng/ml, Insulin (recombinant human) 5 μg/ml, 
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Hydrocortisone 0.33 μg/ml, Epinephrine 0.39 μg/ml, Transferrin-holo (human) 
10 μg/ml, and CaCl2 0.06 mM (Promocell), 100 Units/ml penicillin and 100 
μg/ml streptomycin (Pen/Strep) (GIBCO) and 2.48 μg/ml fungizone (GIBCO).  
Primary ORS keratinocytes at early passages (p3-4) were seeded into 24 well-
plate at a density of 10000 cells per well, and cultured in fully supplemented 
phenol-red free Keratinocyte Growth Medium 2 (Promocell). 
For CRY1 or OPN3 knockdown, ORS cells that were 70% confluent were 
transfected with 50 nM of the corresponding smartpool siRNAs (ON-Targetplus) 
and a non-targeting control (Dharmacon) using Lipofectamine (RNAiMax, 
Invitrogen) according to the manufacturers’ protocol.  
To study CRY1 functions, experiments were initiated with inducing clock 
machinery synchronization with Dexamethasone (Sigma) as a pre-treatment 
(Balsalobre et al. 2000): cells were incubated for 30 minutes with 100 nM of 
Dexamethasone before transfection followed by a washing step in sterile 1x 
PBS (Sigma).  
2.12 Alamar Blue® metabolic activity assay 
Primary ORS keratinocytes at early passages (p3-4) were seeded into 24 well-
plate with a black frame (Porvair) at a density of 60000 cells per well, and 
cultured in fully supplemented phenol red free Keratinocyte Growth Medium 2 
(Promocell). The cell mono-layers were treated with 3.2 J/cm2 light (453 nm) 
using a proprietary LED-based device as described above. The changes in 
metabolic activity were assessed 24 hours after irradiation, using the Alamar 
Blue® assay (Thermofisher) following the manufacturer protocol. The 
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fluorescence intensity of the supernatant was measured using a temperature 
controlled plate reader (FLUOstar OPTIMA, BMG Labtech).  
 
2.13  EdU incorporation assay 
Primary ORS keratinocytes at early passages (p3-4) were seeded into 12 well-
plate on coverslips coated with 0.5% gelatin, at a density of 100000 cells per 
well, and cultured in fully supplemented phenol red free Keratinocyte Growth 
Medium 2 (Promocell), until 80% confluent. Single light treatment with 3.2 J/cm2 
light (453 nm) was performed as described above. After the light treatment, 
cells were incubated with fresh media containing 10 uM of the thymidine 
analogue EdU that incorporates into newly synthesized DNA (Click-iT® EdU 
Imaging Kits, Invitrogen). To investigate if OPN3 is involved in mediating the 
effects of blue light, cells were transfected with either scrambled siRNA (control) 
or siRNA against OPN3 followed by the exposure to 3.2 J/cm2 light (453 nm). 4 
hours and 8 hours after light irradiation the cells were fixed in 4% PFA (10 
minutes, room temperature). EdU detection was assessed following the 
manufacturer protocol. Cell nuclei were counterstained using VECTASHIELD® 
mounting medium containing DAPI (Vector Labs). Image acquisition was 
performed using a ﬂuorescence microscope in combination with DS-C1 digital 
camera and ACT-2U image analysis software (Nikon): 10 to 15 fields of view 
(FOV) from each coverslip were randomly acquired for every condition.  
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2.13.1 Image analysis for EdU positive cells and CDK6 
immunofluorescence in vitro 
Image acquisition was performed using a fluorescent microscope (Nikon Eclipse 
501) and Image Analysis software (Image J) for counting of the number of 
EdU+ cells and cell nuclei visualized using DAPI (Vector Labs) each image. A 
threshold method was used to identify objects in every image; threshold values 
were the same for control and experimental groups. The ratio of proliferative 
EdU+ cells was calculated against the total number of DAPI+ nuclei in every 
FOV. Means±SD was calculated from pooled data (n=10) and statistical 
analysis performed using ANOVA.   
 
To quantify CDK6 nuclear intensity the Integrated Intensity value of the nuclear 
compartment in each cell was analyzed. The average CDK6 nuclear intensity 
for every image was used for statistical purposes. 
 
2.14  Microarray and bioinformatic analysis  
Total RNA was extracted from the ORS cells 48 hours post OPN3 or 24 hours 
post CRY1 siRNA transfection as described above. Quality of total RNA was 
tested by capillary electrophoresis on an Agilent 2100 bioanalyzer (Agilent). 
Gene expression profiling was performed using arrays of human HTA-2_0-st-
type from Affymetrix. Biotinylated antisense cRNA was then prepared according 
to the Affymetrix standard labelling protocol with the GeneChip® WT Plus 
Reagent Kit and the  GeneChip® Hybridization, Wash and Stain Kit (both from 
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Affymetrix, Santa Clara, USA). Afterwards, the hybridization on the chip was 
performed on a GeneChip Hybridization oven 640, then dyed in the GeneChip 
Fluidics Station 450 and thereafter scanned with a GeneChip Scanner 3000. All 
of the equipment used was from the Affymetrix-Company (Affymetrix, High 
Wycombe, UK). A Custom CDF Version 20 with ENTREZ based gene 
definitions was used to annotate the arrays (38). The Raw fluorescence 
intensity values were normalized applying quantile normalization and RMA 
background correction. ANOVA was performed to identify differential expressed 
genes using a commercial software package SAS JMP10 Genomics, version 6, 
from SAS (SAS Institute, Cary, NC, USA). A false positive rate of a=0.05 with 
false discovery rate (FDR) correction was taken as the level of significance. 
2.15  Sorting of hair follicle stem cells  
HF stem cells were isolated from scalp skin of 3 female donors (44-, 66 - and 
70-years-old) as published before (Inoue and Yoshimura 2013). Briefly, skin 
was washed with 1x PBS, hairs were shaved and subcutaneous fat was 
removed using a scalpel. The skin was cut into several stripes of 1 mm width 
and incubated with Dispase I (Roche) overnight at 4°C that allowed separating 
epidermis and the HFs from the dermis using forceps. At least 50 HFs, were 
incubated with 0.05% trypsin- 0.02% EDTA at 37°C for 30 min. After enzymatic 
digestion HFs were transferred into a solution with 10% FBS in 1x PBS to 
neutralize trypsin. Cells were filtered through a 40 um nylon mesh filter, pelleted 
by centrifuging at 170 g for 5 minutes and re-suspended in PBS with 0.5% BSA.   
Cells were labelled with a mix of anti-human PE- conjugated CD200 
(eBioscience), APC-CD34 (eBioscience) and FITC-CD49f integrin (eBioscience)  
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antibodies for 30 min at 4°C in the dark followed by 15 minutes incubation  with 
7-AAD (BD Pharmingen) on ice to identify living cells. Two stem cell 
populations, CD200+/CD49f+ and CD34+/CD49f+, were sorted using Moflo 
XDP cell sorter (Beckman Coulter). Cell populations were sorted based on the 
standard FSC/SSC profile, as well as each fluorochrome and collected in 
TRIzol® LS Reagent for isolation of total RNA. 
2.16  Statistical analysis 
Statistical analysis was performed in Graphpad Prism® (La Jolla, CA, USA). 
Data were assessed for a normal distribution before statistical analysis using a 
D’Agostino-Pearson omnibus normality test. For normally distributed data a 
Student’s T test was used. Where the data did not follow a normal distribution a 
Mann-Whitney test was used. The ANOVA test was used for multiple 
comparisons.  
For the analysis of HF survival rate ex vivo, the effects of medium, donor, and 
light treatments on mean survival time with standard errors, were based on a 
random-effects interval-data regression model. A commercial software package 
was used: StataCorp. 2015. Stata Statistical Software: Release 14. College 
Station, TX: StataCorp LP. 
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3 Results 
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3.1 Analysis of the expression of light-sensitive receptors in 
human hair follicle 
To investigate the expression of putative molecular targets for light therapy in 
human anagen HFs, a screening of Cryptochrome transcription factors and 
Opsins was performed in microdissected HFs by RT-PCR. Primers 
encompassing the Lysine residue, that is required for the photo-activation of 
Opsin receptors, were employed for amplification of OPN1SW (Opsin 1 short 
wavelength), OPN1MW (Opsin 1 middle-long wavelength), OPN2 (Rhodopsin), 
OPN3 (Panopsin or Encephalopsin), OPN4 (Melanopsin), and OPN5 
(Neuropsin) (Haltaufderhyde et al. 2015). To amplify CRY1 (Cryptochrome 1) 
primers annealing to the 5’-UTR region were used. Total RNA isolated from 
human retina and HaCaT cells were used as a positive control.  
Specific PCR products corresponding only to CRY1, OPN2 and OPN3 were 
detected in the HFs, whilst the expression of OPN1 short and middle 
wavelength, OPN4 and OPN5 was not observed (Figure 3-1 A).  
To compare the relative levels of detected Opsins and Cryptochromes in 
anagen microdissected HF, semi-quantitative PCR analysis was performed that 
revealed the higher CRY1 expression levels followed by OPN2 and OPN3 and 
CRY2 in the samples obtained from 6 donors; such expression pattern was sex 
and age independent (Figure 3-1 B). 
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Figure 3-1 Detection of light sensitive receptors in human hair follicles.  
(A) RT-PCR: only OPN2, OPN3 and CRY1 were amplified from HFs cDNA, 
whilst OPN1sw and OPN1mw, OPN4 and OPN5 amplicons were not detected. 
Human retina (R) or HaCaT cell line cDNA were used as positive controls. (B) 
qPCR: relative expression of CRY1, CRY2, OPN2 and OPN3 were measured in 
micro-dissected anagen HFs. CRY1 transcript was highly expressed, followed 
by OPN2 and OPN3, while CRY2 was very low in expression; this pattern was 
sex and age independent in 5 out of 6 patients. Sex and age of each donor are 
below bars clusters (mean ±SD of duplicates). Analysis was performed with 
Genex software (Bio-Rad) using ∆∆Ct equitation method. Abbreviations: M - 
male; F – female (6 donors, 32-67 y.o.). 
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Next, immuno-fluorescence analysis was performed to characterize the 
localization of detected light-sensitive receptors in skin.  
CRY1 is ubiquitously expressed in the epidermis as well as in the dermis 
(Figure 3-2 A). The double staining of CRY1 with cytokeratin 14 (CK14) and 10 
(CK10), markers of the basal and supra-basal layers respectively, showed that 
CRY1 is expressed in undifferentiated and more differentiated keratinocytes 
(Figure 3-2 B-C). In anagen HFs, the expression of CRY1 was detected in the 
dermal papilla, the connective tissue sheath, in the epithelial outer and inner 
root sheaths (Figure 3-2 D) and in the bulge area, known to harbor the stem 
cells of the HFs (Figure 3-2 E). In order to validate that CRY1 is present in the 
HF stem cells, a double immunostaining using CRY1 and CD200, a marker of 
HF stem cells, was performed. The co-expression of CRY1 and CD200 
confirmed the presence of CRY1 in follicular stem cells (Figure 3-2 F). CRY1 
subcellular localization can be nuclear or cytoplasmic, depending on its 
activation state: nuclear CRY1 actively represses transcription of itself and other 
clock genes, inducing rhythmic gene expression (Sancar 2000). In human skin 
and HFs only nuclear expression of CRY1 was observed. However, in primary 
unsynchronized cells isolated from the ORS of anagen HFs CRY1 protein was 
detected in both cytoplasmic and nuclear compartments (Figure 3-2 G). 
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Figure 3-2 Localization of CRY1 in human skin  
Immunofluorescence: (A) CRY1 is expressed in the epidermis and dermal 
fibroblasts. (B) CRY1 (red) is co-localised with CK10 (green), (C) CRY1 (red) is 
co-localised with CK14 (green). (D) In anagen HFs CRY1 expression was 
detected in DP, matrix cells, in the IRS and ORS (arrows). (E) CRY1 expression 
in the bulge area of the ORS (arrow). (F) Co-localization of CRY1 (red) and 
CD200 (green) in the bulge area. (G) CRY1 expression in unsynchronized 
primary ORS cells in both nuclear and cellular compartments. Abbreviations: 
DP - dermal papilla, ORS – outer root sheath. Scale bar 50 µm, nuclear 
staining: DAPI (blue) 
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Prominent expression of OPN2 was seen in the epidermis and in dermal 
fibroblasts in skin obtained from either male beard or female scalp regions 
(Figure 3-3 A-B). OPN2 expression was co-localized with cytokeratin 14 
(CK14), suggesting the presence of OPN2 in the basal epidermal layer (Figure 
3-3 B). In the HF, the expression of OPN2 was restricted to the lower and upper 
ORS (Figure 3-3 C-D-E). Similar pattern of OPN2 expression was detected in 
terminal (Figure 3-3 C-D) and vellus HFs (Figure 3-3 E). In addition, OPN2 
expression was seen in the HF compartment harboring the stem cells (bulge) as 
demonstrated by the double staining of OPN2 with a stem cell marker CD200 
(Figure 3-3F-G).  
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Figure 3-3 Expression of OPN2 in human skin.  
Immunofluorescence: (A) OPN2 is expressed in the epidermis and dermal 
fibroblasts (arrows). (B) OPN2 (red) expression in the basal layer of epidermis 
(arrowheads), which is co-localized with CK14 (green) (C). Expression of OPN2 
(red) in anagen HFs along the ORS (arrows). (D-E) OPN2 expression in the 
lower ORS in terminal (D, arrows) and vellus (E, asterisk) HFs. (F-G) Co-
expression of OPN2 (red) with CD200 (green), a marker of stem cells in human 
HFs. (F-G). Scale bar 50 µm. Nuclear staining: DAPI (blue). Abbreviations: ORS 
– outer root sheath, DP – dermal papilla. 
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Analysis of OPN3 expression revealed its presence in the epidermis, as well as 
in the dermis (Figure 3-4 A). In the HFs, OPN3 expression was predominantly 
seen in IRS and in the lateral hair matrix (Figure 3-4 B). Similar pattern of OPN3 
expression was seen in the scalp terminal (Figure 3-4 B) and vellus HFs (Figure 
3-4 C). The IRS specific OPN3 expression was further confirmed by double-
immunolabelling with AE15 that detects trichohyalin, an intermediate filament-
associated protein involved in the IRS differentiation (Figure 3-4 D). Expression 
of OPN3 was not detected in the hair cortex as it was not co-localized with anti-
hair cortex Cytokeratin AE13 (Figure 3-4 E). Also, co-localization of OPN3 and 
ORS specific Keratin 15 was not observed. (Figure 3-4 F). 
Taken together, our data assert that light –sensitive receptors, such as CRY1, 
OPN2 and OPN3 are expressed in anagen HFs; their specific localization can 
suggest their different roles in hair physiology. 
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Figure 3-4 Expression of OPN3 in human skin. 
(A) OPN3 is expressed in the epidermis and in the dermal fibroblast (arrows); 
(B-C) OPN3 is expressed in the hair matrix (arrows) and in the IRS of terminal 
anagen scalp HF (B) and facial vellus HF (C). (D) Double immunostaining of 
OPN3 (green) with trichohyalin (AE15, red): OPN3 is co-localized with AE15; 
(E) Double immunostaining of OPN3 (green) with hair cortex cytokeratin (AE13, 
red): lack of co-localisation. (F) OPN3 (green) is not expressed in the central 
ORS, as confirmed by double immunostaining with keratin 15 (K15, red). Scale 
bar 50 µm. Abbreviations: DP – dermal papilla, IRS – inner root sheath, ORS – 
outer root sheath. Nuclear staining: DAPI (blue)  
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3.2 Expression of light-sensitive receptors in HF stem cells 
To confirm the preliminary in-situ observations that selected light-sensitive 
receptors are expressed in the HF stem cells ( Figure 3-2 Figure 3-3 G), HF 
stem cells have been sorted from micro-dissected HFs isolated from fresh 
human scalp skin, using a combination of antibodies CD200, CD34 and CD49 f-
integrin markers, as described previously (Ohyama et al. 2006). CD200 is a 
cell-surface marker of the epithelial HFSC found in the bulge region, while 
CD34 is expressed in the HF stem cells of the supra-bulbar ORS (Inoue et al. 
2009; Kloepper et al. 2008; Ohyama et al. 2006; Purba et al. 2014). A 
representative dot plot of the cell populations sorted by FACS is shown in 
Figure 3-5 A: as expected cells from the bulge region, CD200+/CD49+ 
correspond to the 10% of total number of sorted cells, while CD34+/CD200- cell 
population represented 40% of isolated cells. Enrichment in stem cells markers 
was evaluated by RT-qPCR: the bulge CD200+/CD49f+ stem cell population 
was enriched in CD200 and K15 expression; CD34+/CD200- progenitor cells 
exhibited high level of CD34 expression, while expression of K15 and CD200 
was decreased comparing to the bulge stem cells population. Furthermore, the 
expression of K14, a marker of the basal layer of the epidermis, was 
undetectable in sorted stem cells (Figure 3-5 B).  
By qPCR, CRY1, CRY2, OPN2 and OPN3 transcripts were detected in both 
CD200+ and CD34+ cell populations (Figure 3-5 C-D). This analysis confirmed 
that light-sensitive receptors CRY1 - 2 and OPN2 - OPN3 are expressed in the 
HF stem cells- enriched cell population, suggesting a putative light sensitivity of 
HF stem cells. 
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Figure 3-5 mRNA expression of light-sensitive receptors in the hair follicle 
stem cells.  
HF stem cells were sorted from micro-dissected HF (3 donors’ 43-70-y.o.). (A) 
Representative dot-plots showing 2 populations of sorted cells: CD200+/CD49f+ 
bulge stem cells and CD34+/CD200- progenitor cells. (B) Enrichment in stem 
cells markers was evaluated by RT-qPCR: the bulge CD200+/CD49f+ stem cell 
population was enriched in CD200 and K15 stem cells markers. CD34+/CD200- 
progenitor cells expressed high levels of CD34 and low levels of K15 and 
CD200 transcripts; both the CD200+/CD49f+ and CD34+/CD200- cell 
populations had significantly decrease levels of K14 comparing to human 
epidermal keratinocytes (NHK) (n=2, 3 donors in duplicates; mean ±SD). (C) 
OPN2 and OPN3 mRNA expression was detected in both CD200+ and CD34+ 
enriched stem cell populations (n=2; mean ±SD). (D) CRY2 mRNA was highly 
expressed compared to CRY1 mRNA in both CD200+ and CD34+ populations 
(n=2; mean ±SD). Analysis was performed with Genex software (Bio-Rad) using 
∆∆Ct equitation method.  
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3.3 Cry1 is a positive regulator of hair growth  
To explore the functional significance of the identified light-sensitive receptors in 
the HFs, CRY1 activity was modulated in the HF organ culture using either 
chemical or RNA interference approaches. To stabilize CRY1, the small 
molecule KL001 that prevents CRY 1 and 2 degradation and induces 
lengthening of the circadian rhythm was used (Figure 3-6 A). To knock-down 
CRY1 expression in the HF siRNA against CRY1 was employed in the HF ex 
vivo model.  
In a first pilot experiment two concentrations of KL001 (2.7 µM and 8 µM) were 
tested in the ex-vivo HF organ culture to determine the efficacy of CRY1 
stabilization. KL001 prevents CRY1 degradation and induces its translocation 
into the nucleus, where CRY1 activates the negative feedback loop for circadian 
clock regulation, inhibiting its own transcript expression and Period genes 
(Hirota et al. 2012; Oshima et al. 2015). KL001 treatment of HFs resulted in the 
decreased mRNA levels of CRY1 and 2, PER1 and 2 compared to the control 
HFs (Figure 3-6 B). More prominent nuclear expression of CRY1 protein was 
seen in the bulb region (Figure 3-6 C) of the HF treated with 8µM KL001, 
comparing to the control HF (Figure 3-6 D). These observations, consistent in 
three donors, indicate stabilization of CRY1 in the HFs cells upon KL001 
treatment ex vivo (Figure 3-6 D). 
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Figure 3-6 Evaluation of CRY1 stabilization upon KL001 treatment in 
human HF organ culture.  
(A) Schematic representation of KL001 mechanism of action: KL001 prevents 
CRY1 and 2 degradation and induces lengthening of the circadian rhythm 
(Oshima et al. 2015). (B) RT-qPCR: relative expression of CRY1 and 2, PER 
1,2 and 3 were measured in HFs at day 7 post treatment with 2µM and 8 µM 
KL001. CRY1 and CRY2 transcripts were reduced after treatment with 8 µM 
KL001 compared to the control group (DMSO); Period genes expression was 
downregulated with both concentrations of KL001 (n=2; mean ±SEM). Analysis 
was performed with Genex software (Bio-Rad) using ∆∆Ct equitation method. 
(C-D) Prominent nuclear expression of CRY1 protein in the bulb region of the 
HF treated with 8 µM KL001, comparing to the control HF (n=12 from 3 donors, 
Student-t test, *p=0,03). Scale bar: 50 µm. Nuclear staining: DAPI (blue). 
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To determine if stabilization of CRY 1 can affect hair cycle progression, HFs 
were treated with KL001 8 µM every three days. The treatment was performed 
in the insulin depleted medium: insulin is an important growth factor that 
maintains HFs in anagen phase up to 10 days in culture (Philpott et al. 1994a). 
In control HF group, insulin deprivation resulted in the development of 
premature anagen-catagen transition: on day 4, 40% of the HFs entered 
catagen phase. In contrast, in KL001 treated group, the majority of the HFs 
(83%) remained in anagen-like phase (p<0.05, Fisher’s exact test); this 
observation was confirmed in experiments from 4 different individuals (Figure 
3-7 A). Assessment of proliferation and apoptosis was performed using 
immunofluorescence analysis: the number of proliferating Ki-67 positive cells 
was increased in KL001 treated HFs comparing to the control, nevertheless the 
difference was not statistically significant (Figure 3-7 B-C); no differences were 
observed in apoptosis, as the number of TUNEL positive cells was similar in 
KL001 treated and untreated HFs (Figure 3-7 B-C). RT-qPCR analysis revealed 
a significant downregulation of CRY1, PER1,PER2 and PER3 expression after 
KL001 treatment, suggesting that CRY1 is involved in anagen maintenance by 
exerting positive effect on cell proliferation and suppressing the expression of 
PER1 that has been shown to promote pre-mature catagen development (Al-
Nuaimi et al. 2014) (Figure 3-7D). 
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Figure 3-7 Effects of CRY1 stabilization by KL001 on hair growth ex vivo  
(A) Effects of KL001, an activator of CRY1, on HF anagen-catagen transition ex 
vivo were analyzed by monitoring HF gross morphology. Day 4: 84% vs 60% of 
anagen HFs treated with KL001 and the control, respectively (p=0,016, Fisher’s 
exact test). (B) Immunofluorescence: detection of proliferative Ki-67+ cells (red) 
in the hair matrix and apoptotic TUNEL+ cells (green). Scale bar 50 µm. 
Nuclear staining: DAPI (blue). (C) Quantitative analysis revealed the increased 
number of Ki-67+ cells in the HF treated with KL001, that however was not 
statistically significant (Mann-Whitney, p=0,11). No differences in the number of 
TUNEL+ cells. (D) RT-qPCR: down-regulation of CRY1, PER1, PER 2 and 
PER3 transcripts was significant in KL001 treated HFs (n=3, 2 donors in 
triplicates, mean ±SD; One way ANOVA, *p<0.05).  
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To further confirm the positive effects of CRY1 on hair growth, CRY1 siRNA 
was used to knockdown CRY1 expression in HFs. The efficiency of silencing 
was evaluated 96 hours after HF transfection with CRY1 siRNA: more than 60% 
of CRY1 transcript downregulation was achieved that was statistically significant 
(p=0,001, Student T-Test) (Figure 3-8 A). CRY1 protein down-regulation has 
also been confirmed by immunofluorescence (Figure 3-8 B). Intensity for CRY1 
protein staining was substantially reduced in CRY1 siRNA transfected HFs 
(Figure 3-8 B). Effect of CRY1 siRNA on anagen - catagen transition was 
evaluated by morphological analysis and assessment of proliferation and 
apoptosis. At day 4, almost 50% of the HFs in the CRY1 silenced group entered 
catagen, while 80% of the HFs in control group were still in anagen (Figure 
3-8C), which was statistically significant (p=0.002, Fisher’s exact test). 
Assessment of proliferation by quantitative analysis of Ki-67 revealed a 
significant (p=0.028, Mann-Whitney) decrease in the number of proliferating 
cells in the hair matrix and ORS of CRY1 silenced HFs compared to the control 
group (Figure 3-8 D): 75% of Ki-67+ cells were detected in the hair matrix of 
control group, while only 46% of Ki-67+ cells was seen in the hair matrix in the 
HF transfected with siCRY1 (Figure 3-8D). Similar to the KL001 treatment, no 
differences were observed in the number of apoptotic TUNEL+ cells between 
siCRY1 treated and control HFs (Figure 3-8 D).  
Altogether, these results suggest CRY1 has a positive impact on hair growth by 
sustaining proliferation in anagen phase and protecting HF from pre-mature 
entrance into catagen phase.  
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Figure 3-8 Effects of CRY1 silencing on hair growth ex vivo  
Silencing efficacy was evaluated 96 hours after transfection with CRY1 siRNA 
(siCRY1) compared to scrambled control: (A) almost 100% downregulation of 
CRY1 transcript was detected in HFs after Cry1 siRNA transfection (n=9 from 3 
donors, mean ±SD;** p=0,001, Student T-Test). (B) Immunofluorescence 
analysis of CRY1 expression in HFs collected at day 4: statistically significant 
decrease in CRY1 protein expression (red) in siCRY1 transfected HFs 
compared to the scrambled control (n=9 from 3 donors; Mann-Whitney, 
*p=0.0185). (C) In siCRY1 group 43% of HFs entered catagen, while 85% HFs 
remained in anagen in the control (3 donors, mean ±SEM; p=0.002, Fisher’s 
exact test). (D) In control HFs, numerous proliferating Ki-67+ cells (red) were 
detected in the hair matrix and in the ORS (arrows); a significant decrease in 
the number of proliferative Ki-67+ cells (red) was caused by CRY1 silencing 
(n=4, 2 donors; mean ±SEM; Mann-Whitney ,*p=0.028). Difference in TUNEL+ 
cells (green) was not significant between experimental and control groups. 
Scale bar 50 µm. Nuclear staining: DAPI (blue).  
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3.4 Molecular mechanism of action for CRY1 on cell 
proliferation 
To further evaluate the effects of CRY1 on HF keratinocyte proliferation, primary 
synchronized ORS cells were transfected with CRY1 siRNA followed by 
analysis of proliferation using 5-ethynyl-2′-deoxyuridine (EdU) assay that is 
based on incorporation of EdU into newly synthesized DNA of replicating cells. 
Macroscopic analysis of cell morphology did not reveal any difference between 
the cells transfected with either siCRY1 or scrambled RNA for 24 hours (Figure 
3-9 A). Silencing efficiency was confirmed by RT-qPCR: a dramatic decrease in 
CRY1 transcript levels (82%) was detected in siCRY1 transfected cells versus 
the control that was statistically significant (p=0,002), while the expression of 
CRY2 was not affected by CRY1 silencing (Figure 3-9C). PER1, a clock gene 
with similar functions in circadian regulation, was also not affected at transcript 
levels by siCRY1.  
Inhibition of CRY1 in the ORS cells resulted in the significant (p=0,01) decline in 
the number of EdU+ cells compared to the corresponding control (Figure 3-9 
D). Therefore, similar to the HF ex vivo experiments, CRY1 silencing negatively 
affects proliferation in primary ORS. Thus, CRY1 is required for sustaining of 
keratinocyte proliferation in the HF. 
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Figure 3-9 CRY1 silencing inhibits proliferation of outer root sheath cells 
in vitro  
(A) No morphological changes were observed in the ORS cells after 48 h of 
CRY1 silencing (siCRY1). (B) RT-qPCR: dramatic decrease in CRY1 
expression (82%) in the ORS cells due to CRY1 siRNA transfection (n=6 from 2 
donors, mean ±SD). (C) CRY2 and PER1 transcripts were not affected by 
CRY1 silencing (n=3, 2 donors in triplicates, mean ± SD; **p=0,002, Mann-
Whitney). (D) Representative image of EdU assay: the number of proliferating 
ORS cells, assessed with EdU staining (green) significantly decreased 48 after 
silencing of CRY1 (n=10,3 donors, 10 replicates, mean ±SEM, * p= 0.01, 
Student’s t-test). Scale bar 100 µm. Nuclear staining: DAPI (blue). 
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To identify the possible downstream targets of CRY1, the transcriptomic 
profiling of the ORS cells transfected with CRY1 vs control cells was performed. 
Microarray analysis has identified significant changes in the expression of 
genes that are involved in the control of cell proliferation (Figure 3-10 A), 
including Pleckstrin 2 (PLEK2), cyclin-dependent kinase 6 (CDK6), proteasome 
26S subunit non-ATPase 2 (PSMD2), transmembrane BAX inhibitor motif 
containing 6 (TMBIM6), KDEL Endoplasmic Reticulum Protein Retention 
Receptor 1 (KDELR1). The validation of microarray by RT-qPCR in 2 individuals 
confirmed the significant downregulation of CDK6 (p=0,0009), PSMD2 (p=0,05), 
TMBIM 6 (p=0,05), PLEK2 (p=0,0009) and KLER2 (p=0,05) expression in the 
ORS cells due to silencing of CRY 1 (Figure 3-10 B). Because CDK6 is a key 
protein involved in the G1 to S-phase transition, its protein expression was 
further evaluated in the ORS in vitro, using immunofluorescence approach. 
Nuclear staining intensity of CDK6 was measured in each cell and revealed that 
CRY1 silencing caused significant (p<0.05) 56% downregulation of CDK6 in 
ORS cells compared to the control (Figure 3-10 C). Notably, the cells 
expressing CDK6 were EdU negative: this is consistent with the fact that EdU 
binds to actively synthesized DNA (S phase), while CDK6 kinase catalyze G1 
phase progression (Figure 3-10 C).  
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Figure 3-10 Gene expression profiling in ORS keratinocytes transfected 
with siCRY1 identified CDK6 as a downstream target controlling 
keratinocytes proliferation.  
(A) Dot plot of differential gene expression between siCRY1 and control groups 
based on fold-change; the red line demarcates the threshold level of 
significance of the adjusted p-value (p<0,05): PLEK2, CDK6, PSMD2, TMBIM6, 
KDELR1 are significantly downregulated, as emerged by microarray analysis . 
Experiment was performed in triplicates. (B) Validation of microarray by RT-
qPCR (n=6 from 2 donors; mean ±SD; *** p=0.0009, *p=0.05, one way 
ANOVA). (C) Immunofluorescence: decreased CDK6 expression and number of 
EdU+ cells after CRY1 silencing; nuclear staining intensity of CDK6 was 
measured with ImageJ software (n=3, 2 donors in triplicates; mean ±SD; 
*p<0.05, Student’s t-test). Scale bar 50µm. Nuclear staining: DAPI (blue). 
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To investigate if CDK6 is also regulated by CRY1 in HFs, CDK6 expression was 
examined in HFs either transfected with CRY1 siRNA or treated with CRY1 
stabilizer KL001.  
In total human skin, CDK6 expression was found to be restricted to the IRS of 
anagen terminal HFs (Figure 3-11 B). No CDK6 positive cells were observed in 
the epidermis or dermis of human skin (Figure 3-11 A). Similar pattern of CDK6 
expression was seen in the control HF grown ex vivo. However, less prominent 
expression of CDK6 was seen in the proximal IRS of the HF transfected with 
CRY1 siRNA (Figure 3-11 C). In contrast, significant upregulation in the 
expression of CDK6 was detected in the HFs treated with KL001 compared to 
the control (Figure 3-11 D).  
These data provide additional evidence that CRY1 is involved in regulation of 
HF proliferation that is likely mediated by CDK6. 
95 
 
Figure 3-11 CDK6 is a putative mediator of CRY1 activity on cell 
proliferation in the hair follicle.  
(A) Lack of CDK6 expression in the epidermis and dermis of hairless skin (B) 
CDK6 (green) is localized in the IRS of terminal anagen HF. Double 
immunostaining with K15 (red) confirmed absence of CDK6 (green) in the ORS. 
(C) CRY1 silencing results in the reduction of CDK6 expression in lower IRS 
(not significant). (D) KL001 treatment significantly increases CDK6 staining 
intensity in cultured HFs, compared to control (n=6, from 2 donors; mean ±SD; 
*p=0.03, Student’s t-test). Scale bar 50 µm. Nuclear staining: DAPI (blue)  
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3.5 Opsins and hair growth 
As it was shown above OPN2 and OPN3 expression was detected in the 
different compartments of the HF: OPN2 was detected in the ORS (Figure 3-3), 
while OPN3 was expressed in the IRS and lateral hair matrix (Figure 3-4). 
Because expression of OPN3 was detected in the keratinocytes of the IRS that 
do not undergo proliferation, the effect of OPN3 silencing was evaluated in 
highly proliferative cultured ORS cells. Both OPN2 and OPN3 are expressed in 
the primary ORS keratinocytes in vitro, as confirmed by RT-PCR and qPCR in 
three female donors of different age (Figure 3-12 A). The protein expression of 
OPN2 and OPN3 in the ORS cells was seen in their cytoplasm as was 
confirmed by immunofluorescence analysis (Figure 3-12 B).  
OPN3 silencing was performed to investigate the effects of this photoreceptor 
on HF keratinocyte proliferation. Forty-eight hours after silencing of OPN3 no 
gross changes in cell morphology were detected at wide field microscope 
(Figure 3-12 C). Efficiency of OPN3 silencing was confirmed by real-time PCR 
analysis: over 80% decline in OPN3 transcript level was observed in siRNA 
OPN3 treated cells comparing to the control (Figure 3-12 D). Effects on 
proliferation was evaluated employing the EdU assay 48h after siOPN3 
transfection: significant (p<0.0001) decrease in the number of EdU+ cells was 
observed after OPN3 silencing, compared to the scrambled control (Figure 3-12 
E). 
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Figure 3-12 Effects of OPN3 on the outer root sheath cells in vitro. 
(A) RT-PCR: OPN2 and OPN3 transcripts were detected in the ORS 
keratinocytes in vitro; qPCR confirmed expression of both OPN2 and OPN3 in 
primary ORS keratinocytes from 3 female donors of different age (age and sex 
below bars cluster; mean±SD of triplicates) (B) Immunofluorescence: OPN2 and 
OPN3 protein expression was detected in the cytoplasm of the primary ORS 
cells. Scale bar 50 µm. Nuclear staining: DAPI (blue). (C) No morphological 
changes were observed in the ORS cells after 48 hours of OPN3 silencing 
(siOPN3). (D) RT-qPCR: dramatic decrease in OPN3 expression (83%) in the 
ORS cells due to OPN3 siRNA transfection (n=3, triplicates; mean ±SD). (E) 
Representative image of EdU assay: the number of proliferating ORS cells is 
significantly decrease 48 after silencing of OPN3 (n=10, 2 donors, 10 replicates; 
mean ±SD; **** p<0.0001; Student’s t-test). Scale bar 100 µm. Nuclear staining: 
DAPI (blue).  
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Microarray analysis of the global gene expression in the ORS keratinocytes 
treated with OPN3 siRNA or corresponding control revealed the significantly 
(adjusted p-value <0,05) altered expression of 41 genes: 37 were 
downregulated, while only 4 were upregulated due to OPN3 knockdown (Table 
6). Microarray validation by qPCR confirmed that the expression of UL16 
binding protein 1 (ULBP1), p21 protein (Cdc42/Rac)-activated kinase (PAK2), 
follistatin-like 1 (FSTL1) and ubiquitin protein ligase E3 component N-recognin 5 
(UBR5) was downregulated in the ORS cells after OPN3 silencing (Figure 
3-13). In contrast, the expression of sideroflexin 1 (SFNX1), caveolin 2 (CAV2) 
and biogenesis of lysosomal organelles complex 1 subunit 2 (BLOC1S2) was 
increased due to OPN3 silencing in the ORS cells (Figure 3-13). 
Taken together, these data demonstrate that OPN3 downregulation reduces 
proliferation in ORS in vitro and impact the expression of genes that are 
involved in the control of proliferation and apoptosis. 
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Figure 3-13 Effects of OPN3 on the gene expression in outer root sheath 
cells in vitro.  
(A) Microarray: dot plot of the changes in gene expression in primary ORS cells 
after silencing of OPN3, the cut-off line of significant p-value (p<0,05) is 
highlighted in red. Experiment performed in triplicates; (B) Validation of 
microarray by RT-qPCR: knock-down of OPN3 induced downregulation of 
ULBP1, PAK 2, FSTL1, UBR5, and upregulation of BLOC1S2, CAV2, SFXN1 
expression (n=3; mean ± SD; ****p< 0,0001, ***p<0,001, *p<0,05 two-way 
ANOVA). 
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Table 6 List of significantly differentially expressed genes in the outer root 
sheath cells transfected with OPN3 siRNA  
GeneSymbol Full gene name Fold 
change: 
Scrambled 
vs OPN3 
siRNA 
Adjusted p-
Value:  
ULBP1 UL16 binding protein 1 - 4,481 0,000 
PAK2 p21 protein (Cdc42/Rac)-activated 
kinase 
- 3,395 0,004 
FSTL1 follistatin-like 1 - 2,730 0,014 
UBR5 ubiquitin protein ligase E3 
component n-Recognin 5 
- 2,707 0,015 
SERINC5 serine incorporator 5 - 2,681 0,001 
NT5E 5'-nucleotidase, ecto (CD73) - 2,612 0,040 
ELK3 ELK3, ETS-domain protein (SRF 
accessory protein 2) 
- 2,410 0,011 
SPRR2D small proline-rich protein 2D - 2,054 0,028 
NUMB numb homolog (Drosophila) - 2,025 0,037 
TIMM17A translocase of inner mitochondrial 
member 
- 2,001 0,030 
GPRC5A G protein-coupled receptor, class C, 
Group 5 Member A 
- 1,906 0,033 
VAMP3 vesicle-associated membrane 
protein 3 
- 1,857 0,011 
NCKAP1 NCK-associated protein 1 - 1,854 0,013 
RCC2 regulator of chromosome 
condensation 2 
- 1,806 0,010 
F11R F11 receptor - 1,772 0,002 
MSN moesin - 1,751 0,002 
GRB2 growth factor receptor-bound protein 
2 
- 1,744 0,003 
H1F0 H1 histone family, member 0 - 1,731 0,041 
SCRN1 secernin 1 - 1,709 0,032 
ARF4 ADP-ribosylation factor 4 - 1,670 0,013 
ZMYND11 zinc finger, MYND-type containing 
11 
- 1,650 0,047 
MINK1 misshapen-like kinase 1 - 1,541 0,011 
SLC39A9 solute carrier family 39, member 9 - 1,523 0,043 
TMEM38B transmembrane protein 38B - 1,505 0,020 
ZDHHC5 zinc finger, DHHC-type containing 5 - 1,503 0,004 
MAPRE1 microtubule associated protein rp/eb 
family member 1 
- 1,491 0,050 
DSC2 desmocollin 2 - 1,487 0,012 
CERS2 ceramide synthase 2 - 1,478 0,033 
FLNB filamin B, beta - 1,383 0,030 
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CAST calpastatin - 1,362 0,011 
CORO1C coronin, actin binding protein, 1C - 1,323 0,047 
SNX30 sorting nexin family member 30 - 1,298 0,050 
PRMT8 protein arginine methyltransferase 8 - 1,270 0,030 
ENC1 ectodermal-neural cortex 1  - 1,161 0,042 
MITF microphthalmia-associated 
transcription 
- 1,123 0,032 
RNLS renalase, FAD-dependent amine 
oxidase 
- 1,117 0,026 
MIR543 microRNA 543 - 1,065 0,016 
RFX2 regulatory factor X, 2  + 0,933 0,033 
BLOC1S2 biogenesis of lysosomal organelles 
complex 1 subunit 2 
+ 0,867 0,050 
CAV2 caveolin 2 + 0,844 0,043 
SFXN1 sideroflexin 1 + 0,787 0,011 
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3.6 Blue light prolongs anagen phase in hair follicle ex vivo 
As Cryptochromes and Opsins have absorption bands in the blue-to-green 
region (Koyanagi et al. 2013; Sancar 2000; Sugihara et al. 2016) the impact of 
453 nm wavelength light on hair growth was tested by performing daily 
irradiation of HFs ex vivo during 10 consecutive days. 
It has recently been demonstrated that low radiant exposure, 2 J/cm2 of blue 
450 nm light exerts stimulatory effect on reticular and papillary dermal 
fibroblasts (Mignon et al. 2016b). Therefore, irradiance and radiant exposure 
were set to low levels (16 mW/cm2 irradiance, 200 sec illumination duration, 3.2 
J/cm2 radiant exposures) to assure initiation of purely photobiological effects 
and to avoid any photothermal reactions. The impact of low levels of red light 
(689 nm, 16 mW/cm2 and 3.2 J/cm2) has also been evaluated. While this 
frequency mostly lies outside of the absorption band of discovered Opsins, it 
was included in the experiments as red wavelength at low radiant exposure is 
most often used in in vitro and animal experiments and in the devices for in vivo 
hair growth stimulation (Lanzafame et al. 2013; Lanzafame et al. 2014).  
HFs were divided into three groups: a control group was kept in the dark, while 
treated groups were exposed daily to 3.2 J/cm2 of either 689 nm or 453 nm light 
during 10 days. Culture medium was refreshed every other day after light 
irradiation to prevent accumulation of ROS species that can have toxic effects 
on HF. HF gross morphology was monitored daily, using a wide-field 
microscope to distinguish anagen and catagen phases (Figure 3-14 A). An 
interval regression with random intercept model was applied to analyze anagen 
to catagen transition, where mean survival time of a HF in culture (anagen 
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maintenance) was selected as a measure. Effects of medium, donor and light 
treatments on mean survival time from 7 independent experiments are shown in 
Figure 3-14 B. HF growth in the media without insulin was used as a positive 
control for this study. Insulin depletion caused significant premature catagen 
development (p=0) that is consistent with previously published data (Philpott et 
al. 1994b). A donor effect was also statistically significant (p=0.012). This has 
confirmed the applicability and quality of the statistical model. A radiant 
exposure of 3.2 J/cm2 of blue light has little impact increasing mean survival 
time of HF ex vivo, improving anagen maintenance (pairwise comparison 
control versus blue light significant at 10% level, p=0.066) (Figure 3-14 B). In 
contrast, HF treatment with 3.2 J/cm2 of 689 nm light (red light) did not affect 
hair growth compared to the untreated control (pairwise comparison control 
versus red light, p=0.7) (Figure 3-14 B). Positive effects of blue light on hair 
growth was further confirmed by the assessment of proliferation in HFs: the 
number of proliferative Ki-67+ cells was significantly increased at day 2 post 
treatment with low level of blue light compared to the control (p=0.04) (Figure 
3-14 C). 
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Figure 3-14 Effects of 3.2 J/cm2 of blue light with 453 nm central 
wavelength on hair follicle growth ex vivo 
(A) Representative microphotographs of anagen and catagen HFs at day 0 and 
day 7 of the experiment. (B) Effects of medium conditions (with insulin versus 
no insulin), donors and light treatment (blue and red light) on anagen to catagen 
transition expressed as mean survival time with 95% confidence intervals: 
insulin depletion caused premature catagen development as expected; donor 
effect was statistically significant (p=0.012), low levels of blue light increased 
mean survival time, improving anagen maintenance (pairwise comparison 
control vs blue light, significant at 10% level, mean ±SE, p=0.066); red light 
effect was not statistically significant (p=0.7). (C) Immunofluorescence: 
detection of proliferative Ki-67+ cells (green) in the hair matrix. Scale bar 50 µm. 
Nuclear staining: DAPI (blue); quantitative analysis revealed the statistically 
increased number of Ki-67+ cells in the HF treated with blue light (n=8 from 2 
donors; mean ±SD; p=0.04, Student’s t-test). 
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3.7 Opsin 3 silencing abrogates positive impact of low levels 
of blue light on keratinocytes proliferation 
The stimulatory effect of low levels of blue light was further assessed in primary 
ORS keratinocytes. 3,2 J/cm2 of radiant exposure of blue light was tested. 
Stimulation of metabolic activity was assessed with Alamar assay after a single 
treatment with blue light that was significant compared with control group 
(p<0,05) (Figure 3-15 A). To confirm that an improvement in metabolic activity 
was correlated with an increase in cell proliferation EdU incorporation assay 
was performed: significant (p<0.01) increase in proliferation rate was detected 
in ORS cells 8 hours after treatment with 3.2 J/cm2 of 450 nm light, compared to 
the control cells (Figure 3-15 B).  
Evaluation of OPN3 silencing effects after irradiation with 3.2 J/cm2 of blue light 
was assessed to investigate if OPN3 may mediate blue light stimulatory effect. 
Silencing of OPN3 abrogated the positive effect of blue light (3.2 J/cm2, 453 
nm) on proliferation in the ORS cells (Figure 3-15 C). Significant inhibition 
(p<0.0001) in proliferation rate was observed in the ORS cells treated with blue 
light and transfected with OPN3 siRNA compared to the cells treated with blue 
light and transfected with control (scrambled) siRNA (Figure 3-15 C).  
  
109 
 
 
Figure 3-15 OPN3 silencing abrogates blue light stimulatory effect in 
primary outer root sheath keratinocytes.  
(A) Alamar assay: increase in metabolic activity in the ORS keratinocytes in 
vitro after 3.2 J/cm2 of blue light (Student T-test, p=0,0027, n=10; mean ± SEM). 
(B) EdU assay: the number of proliferating ORS cells is significantly increased 8 
hours after blue light irradiation (n=10, 4 donors, 10 replicates; mean + SEM, 
p<0.01, one-way ANOVA). C) Silencing of OPN3 in the ORS cells by siRNA 
significantly decreases proliferation rate compared to the control (scrambled) 
RNA and significantly represses proliferation induced by 3.2 J/cm2 of blue light 
(n=15, 2 donors, 15 replicates; mean + SEM; *p<0,05 , ****p<0,0001, two-way 
ANOVA test). Abbreviations: siSc - siRNA scrambled (negative RNA control); 
siOPN3 - siRNA against OPN3. 
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4 Discussion 
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4.1 Cryptochrome and Opsin receptors are expressed in 
human skin and anagen hair follicles 
Over the last decades, PBM has been suggested as an alternative approach for 
hair loss treatment to drugs. Several clinical studies reported encouraging 
results demonstrating the increase in hair density and thickness in response to 
red and near infrared light-based therapy (Avci et al. 2014). However, the exact 
molecular mechanism underlying light-mediated hair regrowth remains largely 
unknown (Jimenez et al. 2014; Leavitt et al. 2009). The effect of PBM is 
triggered by the interaction of low levels of light with endogenous chromophores 
and photoreceptors in the skin (Mignon et al. 2016a; Vladimirov Iu et al. 2004). 
There is a rich spectrum of molecules absorbing optical radiation over the whole 
visible and near-infrared range (Mignon et al. 2016a; Vladimirov Iu et al. 2004). 
The effects of blue light could be mediated by photolytic generation of NO from 
nitrozated proteins (Liebmann et al. 2010; Oplander et al. 2013), radical oxygen 
species (ROS) formation as a result of enzymatic reactions of e.g. NADPH 
oxidase (Khan and Arany 2015), and COX (Karu 2014). Alternatively, it could be 
mediated by photoactive pigments or chromophores (including the flavin and 
retinal) bound to CRY (Hoang et al. 2008) and Opsin family members 
respectively (Kim et al. 2013b; Wicks et al. 2011), or intracellular calcium and 
light-gated ion channels (Wang et al. 2016). Light interaction with all these 
potential molecular targets could lead to multiple downstream reactions, such 
as changes in pH, [Ca2+], cAMP, ATP, NO (Mignon et al. 2016a; Wang et al. 
2016). 
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In this study, we showed for the first time that CRY1 and 2, OPN2 and OPN3, 
the photoreceptors absorbing light in the visible blue-green wavelength range, 
are expressed in human skin, epithelial and mesenchymal components, and in 
the distinct compartments of the anagen HFs. Our data are in consistence with 
the study of Denda et al who demonstrated the expression of OPN2 in the 
human epidermal keratinocytes (Tsutsumi et al. 2009). In addition, we observed 
specific OPN2 expression in the basal layer keratinocytes expressing Keratin 14 
(Figure 3-3 B). The Oancea group characterized the expression of OPN 1 short 
wavelength, OPN 2, 3 and 5 in human keratinocytes and melanocytes 
(Haltaufderhyde et al. 2015): we confirmed expression of OPN2 and OPN3 in 
epidermal keratinocytes (Figure 3-3 and Figure 3-4 respectively) and also in 
primary ORS cells (Figure 3-12). Intriguingly, the expression of both OPN2 and 
OPN3 was detected also in the HF stem cells (Figure 3-3 F-G, Figure 3-5). 
These findings suggest that the activity of HF and HF stem cells might be 
modulated by blue-green visible light.  
Wavelength falling within the absorption band of discovered Opsins, could 
trigger G protein-related pathways or more complex reaction cascades, 
involving additional chromophores or photoreceptors, for example, cytochrome 
c oxidase, nitrosated proteins, and others (Wang et al. 2016). A similar 
hypothesis was investigated in human orbital fat stem cells: here green-light-
induced directional migration, mediated by ERK signaling pathway, was also 
activated by overexpression of OPN3 (Ong et al. 2013). It has also been shown 
that melanin synthesis induced by UVA in melanocytes is triggered by OPN2 
activation (Wicks et al. 2011). This work demonstrated that G-protein and 
phospholipase C (PLC) activation induced by OPN2 light-mediated stimulation 
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causes calcium (Ca2+) mobilization from intracellular stores in primary 
melanocytes, resulting in early melanin synthesis (Wicks et al. 2011). These 
studies suggest that Opsin receptors could indeed mediate important light 
dependent activities in non-visual tissues. 
CRY1 is a component of the circadian clock machinery that is involved in a 
regulatory negative feed-back loop that determines rhythmicity of the circadian 
cycle (Baggs et al. 2009). CRY1 protein is widely expressed in all tissues of 
human body and plays a fundamental role in defining length of the circadian 
period (Baggs et al. 2009). In mice, expression of clock core proteins (PER2, 
CLOCK and NPAS2) is highly compartmentalized in anagen HF and follows 
circadian rhythmicity: hair matrix and DP are key sites of circadian activity 
(Plikus et al. 2013). Systemic knock-out of either Cry1 or Cry2 in mice abolishes 
synchronization of matrix cell mitosis in the different times of the day in both 
pelage and vibrissae follicles, whilst it does not have effects on hair length or 
hair shaft thickening (Plikus et al. 2013). However, peripheral circadian clock in 
the matrix cells creates daily mitotic rhythm that results in the faster hair growth 
in the morning than in the evening (Plikus et al. 2013). These results support 
the role of CRY1 in enforcing coordinated cell cycle checkpoint (Gaddameedhi 
et al. 2011; Geyfman et al. 2012b). For this reason and because CRY1 was 
suggested to act as a putative light-sensitive receptor (Sancar 2000; Thresher 
et al. 1998), the significance of the CRY family members in the regulation of 
human hair cycle was investigated in this project.  
RT-PCR confirmed the presence of CRY1 transcript in anagen HF (Figure 3-1 
A) and quantitative PCR showed that both CRY1 and CRY2 mRNA are 
expressed in anagen HF (Figure 3-1 B) and in sorted HF stem cells (Figure 3-5 
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D). It has previously been shown that nuclear ratio of CRY1/CRY2 proteins 
controls the circadian length in a bidirectional manner: more CRY1 causes 
lengthening of the periods, while more CRY2 causes shortening of the periods 
(Anand et al. 2013; Hirota et al. 2012; Zhang et al. 2009). Therefore, a 
quantitative evaluation of differences in CRY1/2 ratio in HF stem cells and more 
differentiated HF cells would give indirect information regarding differences in 
the circadian length in the different cell types. How this balance could influence 
proliferation and differentiation processes in the HF, and how it affects the hair 
cycle is beyond the objective of this project, but worthy of further investigation.  
 
4.2 Discovered light receptors are mediator of hair cycle 
regulation 
4.2.1 CRY1 delays hair follicle catagen entry via CDK6 
Increasing evidence suggest a fundamental role for the clock machinery in the 
regulation of the hair cycle (Al-Nuaimi et al. 2014; Plikus et al. 2013). HF growth 
consists of cyclic events of degeneration and regeneration, mainly regulated by 
signaling between DP and HF stem cells (Rompolas and Greco 2014). The 
master regulators of the timing between different hair cycles phases have not 
been clearly identified yet. A role for the circadian clock in hair cycle control has 
been hypothesized: Clock and Bmal1 mutant mice exhibit a delay in anagen 
progression (Lin et al. 2009); downregulation of the same genes in HF organ 
culture determine prolongation of the anagen phase (Al-Nuaimi et al. 2014); a 
different susceptibility of HFs to γ-irradiation during the day disappears in 
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Cry1−/−; Cry2−/− mutant mice, suggesting a role for CRYs in preventing hair 
loss induced by the external stressors (Plikus et al. 2013). 
In our experiments, stabilization of CRY1 protein delayed anagen to catagen 
transition ex vivo (Figure 3-7), while downregulation of CRY1 promoted early 
entrance into the catagen phase (Figure 3-8). Marked reduction in proliferative 
events in the hair matrix and the ORS layer was observed after CRY1 silencing 
(Figure 3-8 D). Stabilization of Cryptochromes was performed using the small 
synthetic molecule KL001 (Figure 3-6 A) (Hirota et al. 2012) that specifically 
binds to CRY proteins preventing ubiquitin-dependent degradation of CRY 
(Hirota et al. 2012). The opportunity to use a tool that selectively targets one of 
the core clock proteins allowed us to study the role of CRY in hair physiology. 
Treatment with KL001 significantly decreased levels of PER1 in HF organ 
culture (Figure 3-6). The same effect was consistently observed in 
unsynchronized U2OS cells, where KL001 resulted in the decline of PER1 
levels at transcript and protein levels, while nuclear protein levels of CRY1 and 
2 were increased, despite a reduction in mRNA expression (Hirota et al. 2012). 
Recently Al-Nuaimi et al found that PER1 expression is upregulated in catagen 
HF, and that PER1 silencing prolongs anagen phase in HF organ culture (Al-
Nuaimi et al. 2014). Therefore, CRY1 may promote anagen maintenance 
inhibiting the expression of PER1, which leads to stimulation of keratinocytes 
proliferation.  
Impairment of clock machinery has well known effects on cell cycle. For 
example, liver regeneration was impaired in Cry1 and 2 deficient mice (Matsuo 
et al. 2003); the molecular analysis suggested that the circadian clock may 
affect cell division by regulating the expression of the E-box–containing gene 
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Wee1, which encodes a kinase involved in timing of M phase entry (Matsuo et 
al. 2003). In Cry1 and 2 double knock-out mice proliferative Pcna-positive cell 
population is expanded distally above the Auber line in anagen hair follicle, 
compared with wild type. Nevertheless no increase in the total number of mitotic 
events was observed in double mutant mice (Plikus et al. 2013). This was 
explained by inability of ectopic PCNA+ cells to complete mitosis, due to pro-
differentiation signaling via non circadian mechanism that would counteract the 
effect of clock oscillator’s disruption. In our experiments, only CRY1 was 
targeted that resulted in the significant decrease in cell proliferation that lead to 
pre-mature catagen initiation (Figure 3-8).  
Several studies demonstrated a tissue-specific regulation of gene expression by 
clock transcription factors (Balsalobre et al. 1998; Storch et al. 2002). 10% of 
the genes expressed in liver and 8% of the genes expressed in the heart 
showed circadian regulation; liver and heart circadian gene sets revealed very 
little overlap, suggesting a tissue specific gene expression regulation of 
circadian clocks (Storch et al. 2002). In synchronized fibroblasts, 81 novel 
genes following a robust circadian pattern were identified; interestingly, within 
this group, several transcripts belonged to the genes involved in cell cycle 
regulation such as Cyclin D3 and CDK4, known to play a role in the G1/S 
transition (Grundschober et al. 2001). Double Cry1 and 2 knock-out mice 
exhibited constant and arrhythmic expression of important players in the cell 
cycle regulation, such as Cyclin-dependent kinase 2 protein (CDK2) (Plikus et 
al. 2013), making clear the link between the clock machinery and cell cycle 
regulation.  
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To evaluate if specific mediators of the cell cycle were activated by CRY1 in the 
HF cells we performed microarray analysis after CRY1 silencing. We confirmed 
that in primary ORS cells downregulation of CRY1 also significantly suppressed 
proliferation (Figure 3-9 D). Silencing of CRY1 did not affect the expression of 
any of the others clock genes with similar function, CRY2 and PER1, 
suggesting that the analysis is restricted to the genes that are specifically 
targeted by CRY1 (Figure 3-9 C). CRY1 silencing significantly reduced 
expression of genes involved in cell cycle regulation: Pleckstrin 2 (PLEK2), 
cyclin-dependent kinase 6 (CDK6), proteasome 26S subunit, non-ATPase 2 
(PSMD2), transmembrane BAX inhibitor motif containing 6 (TMBIM6), KDEL 
Endoplasmic Reticulum Protein Retention Receptor 1 (KDELR1) (Figure 3-10 
B). Nothing is known about these genes in relation to hair physiology but all 
genes were shown to be involved in promoting cell proliferation in other models. 
PSMD2, in addition to participation in proteasome function, may be involved in 
the TNFα signaling pathway, interacting with the tumor necrosis factor type 1 
receptor (TNFR) (Dunbar et al. 1997). TNFα is known to promote catagen, as 
shown by its inhibitory effect on hair growth in vitro (Philpott et al. 1996). TNFR 
is also involved in HF fate regulation: deficient mice for the receptor have 
defects in HF induction, lack sweat glands and exhibit tooth malformation 
(Botchkarev and Sharov 2004; Headon and Overbeek 1999). PLEK2 interacts 
with the actin cytoskeleton to induce cell spreading (Hamaguchi et al. 2007): 
increased levels in PLEK2 expression were found in melanoma patients, 
suggesting a fundamental role for this protein in sustaining proliferation (Luo et 
al. 2011). TMBIM6 is a multi-transmembrane domain-spanning endoplasmic 
reticulum (ER)-located protein that is evolutionarily conserved: TMBIM6 protects 
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against apoptosis (Xu and Reed 1998), is a negative regulator of the 
endoplasmic reticulum stress (Lisbona et al. 2009) and reduces the production 
of reactive oxygen species through direct interaction with NADPH-P450 
reductase (Kim et al. 2009), a member of the microsomal monooxygenase 
system. 
CDK6 is a member of the cyclin-dependent protein kinase (CDK) family that 
includes CDK4 and CDK2 kinases. CDK proteins are involved in the control of 
the cell cycle and differentiation. CDK6 promotes G1/S transition via 
phosphorylation of pRB/RB1 and NPM1 (Sherr and Roberts 1999; Weinberg 
1995). CDK6 is also involved in the initiation and maintenance of cell cycle exit 
during cell differentiation (Grossel and Hinds 2006).  
Since the role of CDK6 in HF is still unknown, we performed 
immunofluorescence analysis to characterize localization of this kinase in 
healthy full thickness skin. Surprisingly, we discovered that CDK6 specifically is 
localized in the cytoplasmic compartment of the IRS cells of anagen HFs 
(Figure 3-11 B), while we have been able to detect nuclear signal for CDK6 in 
primary ORS cells (Figure 3-10 C). A cytoplasmic localization for CDK6 has 
been shown in U2OS cells (Grossel et al. 1999), T cells (Mahony et al. 1998; 
Nagasawa et al. 1997) and mouse astrocytes (Ericson et al. 2003) that is similar 
to our observations in the HF. Specific compartmentalization of CDK6 can be 
related to its ability to create a functional complex that are translocated into the 
nucleus (Grossel et al. 1999; Mahony et al. 1998), or an alternative cytoplasmic 
role for CDK6 was suggested: cdk6 protein was found to be located in the 
ruffling edge of spreading cells in MRC5 human fibroblast and the ability to 
suppress p16INK4a-mediated inhibition of cell division was shown, indicating a 
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function in controlling matrix-dependent cell spreading. (Fåhraeus and Lane 
1999).  
Our results demonstrated a correlation between CRY1 expression and levels of 
CDK6, which could suggest that CRY1 alters cell proliferation in HF ex-vivo via 
CDK6 activity. The hypothesis that the cellular clock regulates the cell cycle via 
interaction with CDK/Cyclin molecular gates has previously been evaluated: 
Plikus et al work suggests that clock generates daily mitotic rhythmicity in hair 
matrix by synchronizing Cdc2/Cyclin B-mediated G2/M checkpoint (Plikus et al. 
2013). It has also been shown a pro-proliferative effect for CDK6, which activity 
was elevated in squamous cell carcinomas (Timmermann et al. 1997).  
However, it is not clear why CDK6 is specifically localized in the IRS of anagen 
HF, a region of differentiated cells, and how this could affect the proliferating 
matrix cells. Nevertheless, recent findings indicate a novel and specific role for 
CDK6 in regulation of differentiation in multiple cell types. Sustained expression 
of CDK6, but not of CDK4 kinase, blocked differentiation of mouse erythroid 
leukemia cells (Matushansky et al. 2000; Matushansky et al. 2003). In mouse, 
aberrant levels of CDK6 in the astrocytes caused rapid changes in morphology 
from a more differentiated to a precursor-like state; this was also confirmed by 
an altered expression of differentiation markers (Ericson et al. 2003). BMP2-
SMAD signaling-induced differentiation in mouse osteoblasts was associated 
with strongly down-regulated CDK6 expression (Ogasawara et al. 2004b). In 
osteoclasts, CDK6 was found to be a key determinant of the differentiation rate 
and act as a downstream effector of NF-kappa B signaling (Ogasawara et al. 
2004a). However, the precise mechanism by which CDK6 regulates cell 
differentiation is still not fully clear.  
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Interestingly, inhibition of CDK4/6 in the skin completely blocks HF growth and 
differentiation (Benjamin et al. 2003). However, this effect was only observed 
when CDK4/6 were inhibited at the time of the hair cycle induction by epilation 
(day 0 of epilation), while CDK4/6 were dispensable for hair cycle progression. 
This evidence suggest that hair cycle can be activated by CDKs pathway only 
within a specific temporal window (Benjamin et al. 2003). Therefore, we are 
tempted to speculate, that differences in timing and activity of CDK6 during hair 
cycle could be regulated by the clock machinery system, and specifically by 
CRY1.  
 
4.2.2 OPN3 is involved in the regulation of keratinocytes proliferation in 
the hair follicle  
We have demonstrated that OPN3 exerts a positive effect on ORS cells 
proliferation (Figure 3-12 E). In vitro analysis of the effect of OPN3 
downregulation revealed the significant decrease in the number of proliferative 
EdU positive cells, compared to the corresponding controls (Figure 3-12 E). 
Transcriptomic analysis detected that silencing of OPN3 expression in the 
proliferating ORS keratinocytes leads to the altered expression of genes 
involved in the control of stem cell activity in skin and HF (Figure 3-13). For 
example, the expression of p21-activated kinase 2 (PAK2) and follistatin-like1 
(FSTL1) was downregulated due to OPN3 silencing. PAK2 plays a role in a 
variety of different signalling pathways including cytoskeleton regulation, cell 
motility, apoptosis or proliferation. PAK2 acts as a downstream effector of RAC1 
that leads to the inhibition of c-Myc (Benitah et al. 2004; Huang et al. 2004). 
Both RAC1 and c-Myc are implicated in the control of epidermal stem cell 
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(Benitah et al. 2005). In epidermal stem cells c-Myc activation causes a 
progressive reduction in the growth rate in vitro without inducing apoptosis due 
to a marked stimulation of terminal differentiation (Gandarillas and Watt 1997; 
Watt 2000). c-Myc overexpression in vivo promotes basal keratinocytes exit 
from the stem cell compartment, inducing preferential differentiation into 
sebocytes lineages at the expenses of hair differentiation (Arnold and Watt 
2001). Interestingly, c-Myc was found to be expressed in several compartments 
of the anagen human HF, including the hair bulb, proximal IRS and the bulge 
region (Bull et al. 2001; Rumio et al. 2000). Evidence about c-Myc localization in 
the IRS and our finding about PAK2 downregulation caused by OPN3 silencing 
suggest the possible functional link between OPN3 and c-Myc in the regulation 
of HF cell proliferation/differentiation. FSTL1 is another very attractive OPN3 
target gene, because it is known that FSTL1 inhibits bone morphogenetic 
protein (BMP) suppressive effects in telogen HF stem cells allowing the 
initiation of the new hair cycle (McDowall et al. 2008).  
These findings highlighted a novel previously unrecognised role for OPN3 in cell 
cycle modulation in the HF cells. Taken together, the identified light-sensitive 
receptors in the HF, Cryptochromes and Opsins, can be involved in the hair 
cycle control.  
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4.3 Blue light prolong anagen ex vivo and its stimulatory effect 
can be mediated by OPN3 
In recent years, several molecules have emerged as novel mediators of light 
activation in non-photosensitive tissues, such as nitrosated proteins regulating 
nitric oxide (NO) (Liebmann et al. 2010; Oplander et al. 2013), the ﬂavoprotein-
containing Cryptochromes (Bouly et al. 2007) and Opsins (Wicks et al. 2011). 
Despite such a long list of potential absorbers of blue light, the shorter-
wavelength UV-free part of the electromagnetic spectrum remains to be 
relatively unexplored. The latter could possibly be explained by a relatively short 
penetration depth of this part of the electromagnetic spectrum. However, 450 
nm light is successfully used for treatment of cutaneous diseases, including 
psoriasis and eczema (Keemss et al. 2016; Pfaff et al. 2015), suggesting 
sufficient blue light penetration into the skin. A novel device has recently been 
developed for percutaneous light delivery. This device incorporates a microlens 
array that focuses the light through the needle tips at specific points and can 
achieve the required intensity profile within the tissue, overcoming the limitation 
of blue light penetration in the skin (Kim et al. 2016). A 9-fold enhancement of 
light delivery was achieved in bovine tissues that could be approximated to 1.3 - 
2.5 mm depth penetration through the human skin (Kim et al. 2016). Similar 
additional optical beam manipulations might allow the photons of blue light at 
sufficient density to reach HF epithelial cells, including the bulge stem cells 
located in the outer root sheath or DP and matrix cells of miniaturized AGA HFs.  
Photosensitivity of visual Opsins requires binding of the 11-cis-retinal 
chromophore to a Lysine residue of the G protein coupled receptors. While 11-
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cis retinal is abundantly present in the eye to ensure the formation of a 
functional receptor, all-trans retinal are mostly present in non-photosensitive 
tissues (Koyanagi et al. 2013; Miyagi et al. 2001). Nevertheless, it has been 
reported that homologs of vertebrate OPN3 in pufferfish and mosquito becomes 
light sensitive when they bind to 13-cis-retinal, and they might function as 
photoreceptors in many tissues (Miyagi et al. 2001). Photosensitivity of 
Cryptochromes in mammals has been largely debated (Grossel and Hinds 
2006) but is now considered that they perform both light-dependent and light-
independent functions in the regulation of the circadian clock (Lin and Todo 
2005). In addition has been shown that their role in the light entrainment of the 
circadian clock can be carried out redundantly by other photoreceptors, more 
likely Opsins (Panda et al. 2002). 
Therefore, the expression of CRY1 and 2, OPN2 and OPN3 in the different HF 
compartments and their role in hair physiology, stimulated our interest in 
understanding their possible involvement in light sensing capability of the HF.   
It has been demonstrated that keratinocyte irradiation with blue light of 412-426 
nm at relatively high radiant exposure causes toxic effects (Liebmann et al. 
2010). In addition, 41.4 J/cm2 453 nm blue light irradiation rapidly induces ROS 
production and anti-proliferative effects (Becker et al. 2016; Liebmann et al. 
2010). In our study, we observed that low level of light at 453 nm wavelength 
(which falls within Opsins and Cryptochromes absorption spectrum) promote 
anagen phase in HF ex vivo associated with sustained proliferation in the hair 
matrix keratinocytes compared with untreated control (Figure 3-14). 
Interestingly, low radiant exposure of 3.2 J/cm2 stimulated metabolic activity in 
the ORS cells in vitro 24 hours after treatment, and promotion of cell 
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proliferation was significant only 8 hours after light irradiation (Figure 3-15 A-B). 
This suggests that light exerts a long term effect that is likely to be triggered by 
changes in gene expression levels in the affected cells. A positive effect of low 
levels (2 J/cm2) of 453 nm blue light has recently been demonstrated in the 
dermal fibroblasts: the activation of metabolic activity and even more, the 
increased collagen production by papillary fibroblasts (Mignon et al. 2016b), and 
increased total protein synthesis (Masson-Meyers et al. 2016). Therefore, these 
reports suggest that low levels of blue light could promote positive effects on 
cell growth and functions. In line with it, our study demonstrated that 3.2 J/cm2 
of blue light with 453 nm central wavelength exert beneficial effect on anagen 
maintenance of HF ex vivo.  
Despite numerous existing publications about responsiveness of HFs and HF 
cells to red light and existing commercial red light-emitting devices for hair 
growth stimulation, in our study 3.2 J/cm2 of 689 nm light (red light) did not 
significantly affect hair growth ex vivo (p=0.7). However, this lack of statistical 
significance does not necessarily serve as evidence of the absence of positive 
effect of red light (Figure 3-14). A recent viewpoint review (Mignon et al. 2016a) 
that summarizes the investigation of 90 reports published between 1985 and 
2015, mostly based on application of red and near-infrared light, identified major 
inconsistencies in optical parameters between the published studies. A variety 
of the optical ranges of photon density applied in in vitro and ex vivo settings 
has been shown to encompass over two orders of magnitude. Strikingly, same 
or very similar optical parameters used in different studies have been reported 
to trigger diverse effects on the cell (Liebmann et al. 2010; Pellicioli et al. 2014; 
Prabhu ; Song et al. 2003). It has also been shown that culture conditions can 
125 
 
have a huge impact on the outcome of the experiments with light (Mignon et al. 
2016b). Therefore, even if the beneficial effect of blue light at low radiant 
exposure on hair growth raises a possibility to use these parameters for future 
therapeutic solutions, it is important to emphasize the limit of selected 
experimental conditions when translating in vitro results into in vivo scenarios. 
Importantly, the stimulatory effect of blue light on ORS cell proliferation was 
abrogated by silencing of OPN3; downregulation of OPN3 in vitro dramatically 
reduced proliferation rate, which was otherwise induced by blue light treatment 
in primary ORS cells (Figure 3-15 C).  
These findings support our hypothesis that positive effects of blue light on hair 
growth could be mediated, at least in part, by light-sensitive receptors such as 
OPN3. Further investigation will be required to understand the role of others 
light mediators, if light effects are triggered by a specific photoreceptor, or more 
likely by a cascade of pathways activated by different receptors.  
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5 Conclusions 
 
In this project, a novel role for light-sensitive receptors in the control of human 
hair growth was identified. Based on the data obtained in this study the 
following conclusions can be made:  
1. The light-sensitive receptors, such as CRY1, CRY2, OPN2 and OPN3 
are expressed in the distinct compartments of the human HF. CRY1 is 
ubiquitously expressed throughout the HF; OPN2 and OPN3 are 
localized in the ORS and the IRS layers of the anagen HF, respectively; 
CRY1, CRY2, OPN2 and OPN3 transcripts were also detected in the HF 
stem cells. 
2. CRY1 prolongs anagen phase by stimulating cell proliferation, at least in 
part via cell cycle kinase CDK6: CRY1 stabilization induced by KL001 
treatment in HF ex vivo lengthens anagen phase; CRY1 silencing 
promotes early entrance into catagen phase associated with substantial 
reduction in cell proliferation; CRY1 silencing dampens CDK6 
expression; KL001-mediated anagen prolongation is accompanied with 
the enhanced CDK6 expression. 
3. OPN3 could have a positive effect on hair growth: OPN3 silencing in 
primary ORS cells negatively impacts proliferation, due to the altered 
expression of genes involved in the regulation of proliferative and 
apoptotic pathways.   
4. Blue light (3,2 J/cm2 , 453nm) exerts a positive effect on hair growth ex 
vivo, potentially via interaction with OPN3: blue light increases the mean 
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survival time of HF ex vivo, stimulating proliferation of the hair matrix 
cells. 3,2 J/cm2 of blue light also boosts the metabolic activity in primary 
ORS and significantly promotes in vitro cell proliferation, which is 
abrogated by silencing of OPN3.  
Taken together, the data obtained in this project suggest that human HF 
exhibits the expression of a variety of light-sensitive receptors that could 
mediate the effects of light on hair growth. The further research should be 
conducted to decipher direct interactions between blue light and Cryptochromes 
and Opsin receptors in the HFs, as well as to investigate a role of other blue-
light acceptors in the control of hair growth. The beneficial effect of blue light at 
low radiant exposure on hair growth raises a possibility of increasing therapeutic 
efficacy when combined with topical chemistry used for management of hair 
growth disorders.  
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